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SOME CONCLUSIONS OF STATISTICAL ANALYSIS OF THE 
 SPECTROPSCOPIC EVALUATION OF CERVICAL CANCER 
by  
Hailun Wang 
Under direction of Yu-sheng Hsu 
ABSTRACT 
To significantly improve the early detection of cervical precancers and cancers, 
LightTouch™ is under development by SpectRx Inc..  LightTouch™ identifies cancers 
and precancers quickly by using a spectrometer to analyze light reflected from the 
cervix.  Data from the spectrometer is then used to create an image of the cervix that 
highlights the location and severity of disease. 
Our research is conducted to find the appropriate models that can be used to 
generate map-like image showing disease tissue from normal and further diagnose the 
cervical cancerous conditions.  Through large work of explanatory variable search and 
reduction, logistic regression and Partial Least Square Regression successfully applied to 
our modeling process.  These models were validated by 60/40 cross validation and 10 
folder cross validation.  Further examination of model performance, such as AUC, 
sensitivity and specificity, threshold had been conducted. 
INDEX WORDS:  Cervical cancer, Logistic Regression, Partial Least Square 
Regression, AUC, Sensitivity, Specificity, Threshold 
 
 
 
  
SOME CONCLUSIONS OF STATISTICAL ANALYSIS OF THE  
SPECTROPSCOPIC EVALUATION OF CERVICAL CANCER 
 
by 
 
Hailun Wang 
 
 
A Thesis Submitted in Partial Fulfillment of Requirements for the Degree of  
Master of Science  
in the College of Art and Sciences  
Georgia State University 
 
 
 
 
 
 
 
 
2007 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Hailun Wang 
2007 
  
SOME CONCLUSION OF STATISTICAL ANALYSIS OF THE  
SPECTROPSCOPIC EVALUATION OF CERVICAL CANCER 
 
 
by 
 
 
Hailun Wang 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronic Version Approved: 
 
Office of Graduate Studies 
College of Art and Sciences 
Georgia State University 
August 2007 
        Major Professor:    Yu-sheng Hsu 
Committee:             Mark Faupel 
                                Xu Zhang 
                
  
iv
ACKOWLEGEMENTS 
First of all, I sincerely and gratefully acknowledge my advisor, Dr. Yu-sheng 
Hsu, for his guidance, patience and gracious support. I greatly benefit from his 
invaluable suggestion.  
I owe special appreciation for Dr. Mark Faupel, President and Chief 
Executive Officer and Dr. Shabbir Bambot, Senior director of SpectRx, who 
provided me this great opportunity to experience the real world and supervised me 
throughout my internship. I thank David Mongin and Rick Fowler in SpectRx for 
helping me developing my skill as a team member.  I also thank Chenghong Shen 
and Yi Li for their help during the project. 
Special thanks go to my husband and my parents.  They helped me through 
the frustrating and difficult times with support and love.    
 
 
                                                   
 
 
 
 
 
 
 
 
 
 
 
  
v
Table of Content 
Acknowledgements………………………………………………………….             iv 
List of Tables…………………………………………………………………            vi 
List of Graphs………………………………………………………………..           viii 
List of Abbreviations…………………………………………………………            ix 
Chapter one: Introduction…………………………………………………….             1 
Chapter two: Point Level Algorithm………………………………………….             4 
2.1 Data Manipulation and Variable Selection…………………….             4 
2.2 Methodologies…………………………………………………              7 
2.3 Results and Conclusion………………………………………..            12 
Chapter three: Diagnostic Methods………………………………………….            19 
3.1 Data Manipulation and Variable Selection……………………            19 
3.2 Methodologies………………………………………………..              26 
3.3 Results and Conclusion……………………………………….             28 
Chapter Four: Future Study………………………………………………….            36 
Reference…………………………………………………………………….            38 
Appendix I: SAS Code for Initial Data Manipulation, Variable  
Reduction in Point Analysis……………………………………             41 
Appendix II: SAS Code for Creating New Variables in Point Analysis  
Using Tissue Type…………………………………………….            46 
Appendix III: SAS Code for Creating New Variables in Point 
  
vi
 Analysis Using Percentiles in Peripheral Group…………………………                 50 
APPENDIX IV: SAS Code for Calculating AUC on Training   
and 10-floder cross-validation datasets…………………………………..                  52 
APPENDIX V: SAS Code for Data Manipulation and  
Percentile Variable Creation in Whole Cervix Diagnosis…………………                57 
APPENDIX VI: SAS Code for Read Pilot Data into  
Alpha Pick and Beta Pick Sets……………………………………………                 63 
APPENDIX VII: SAS Code for T-test and Wilcoxon Test………………..                70 
APPENDIX VIII: SAS Code for Generating Coefficients 
 of All Whole Cervix Model ……………………………………………...                73 
APPENDIX IX: SAS Code for Sensitivity and Specificity  
Calculation ……………………..…………………………………………                79 
 
 
 
 
  
 
 
 
 
 
  
vii
List of Tables 
Table 2.1: Lookup table for excluding points……………………………………             5                         
Table 2.2: Spectrum data structure in database ………………………………….            5 
Table 2.3: Pathology variable index …………………………………………….             6 
Table 2.4: 2x2 classification table ……………………………………………….          10 
Table 2.5: earlier study results of point level diagnosis………………………….          12 
Table 2.6: Normalized data structure (e.g. Patient 1001) ……………………….           13 
Table 2.7: Effectiveness of Normalization process --- Tissue Type ……………           13 
Table 2.8: Effectiveness of Normalization process --- Percentile ………………           15 
Table 2.9: Model performance comparison --- RGB image information ……….           16 
Table 3.1: Variable flip index ……………………………………………………           2 2 
Table 3.2: Pap variable index ……………………………………………………          25 
Table 3.3: Pathology variable index ……………………………………………..          26 
Table 3.4: Variable Reduction Performance ……………………………………..          28 
Table 3.5: Wilcoxon Rank for Ratio Variables ………………………………….           29 
Table 3.6: Model performance comparison chart I ……………………………...          30 
Table 3.7: Model performance comparison chart II ……………………………..          32 
Table 3.8: Model performance comparison chart III …………………………….          32 
Table 3.9: Model performance comparison chart IV …………………………….          33 
Table 3.10: Model performance comparison chart V …………………………….         34 
Table 3.11: Ratio Variables List …………………………………………………..         34 
  
viii
Table 3.12: Model performance comparison chart VI …………………………            35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ix
List of Graph 
Graph 2.1: Data manipulation process ……………………………………..                    7 
Graph 2.2: Cervix surface divided by peripheral vs central ………………..                  14 
Graph 2.3: Cervix surface color map ………………………………………                  16 
Graph 3.1: Mean of P25 spectra for 522 Training subjects ………………..                   20 
Graph 3.2: Mean of P75 spectra for 522 Training subjects ………………..                   21 
Graph 3.3: Ratio variable specificity performances under 95% sensitivity...                  23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
x
List of Abbreviations 
ASC-US     Atypical Squamous Cells of Undetermined Significance  
AGUS       Atypical glandular cells of undetermined significance 
CIN         Cervical Intraepithelial Lesion 
CN         Columnar Normal 
FDA        Food and Drug Administration 
LSIL        Low Grade Squamous Intraepithelial Lesion 
Pap         Papanicolaou test 
PLS         Partial Least Square 
SN          Squamous Normal 
TZ          Transformation Zone 
 
 
 
 
 
 
 
 
 
 
 
 
  
1
Chapter One: Introduction 
 
According to published reports, cervical cancer is the second most common 
cancer among women worldwide. Globally, there are approximately 371,000 cases of 
cervical cancer diagnosed annually and approximately 190,000 deaths per year [1].  The 
incidence of cervical cancer is on the decline in more developed countries, largely due to 
implementation of the Pap test. 
The most common findings on a Pap test are ASC-US and LSIL which provoke 
millions of follow-up Pap tests, colposcopies and biopsies. However, only about 5% of 
ASC-US and 10% of LSIL Paps actually reflect an immediate cancer precursor.  Even 
with colposcopy, diagnosis is imperfect, with 50% - 80% sensitivity and around 50% 
specificity [3], [4].  All of these mean that a significant number of women were 
misclassified through diagnosis of colposcopies and biopsies. 
LightTouch™, under development by SpectRx Inc., is being designed as a new 
non-invasive test.  LightTouch™ identifies cancers and precancers quickly by using a 
spectrometer to analyze light reflected from the cervix.  Data from the spectrometer is 
then used to create an image of the cervix that highlights the location and severity of 
disease. 
Florescence and reflectance spectroscopy have been shown to be valuable in 
cancer diagnosis by some investigators [4].  A number of studies show the performance of 
either spectroscopy in discriminating between normal tissue and different epithelial 
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cancer grades use point measurements of area that are either suspect or normal.  As an 
example, studies from the Richard Kortum’s Lab indicate that variability between 
normal tissues in different patients is higher than variability between tissues with disease 
grades [5], [6].  In addition, reflectance spectra of cervical pre-cancer show consistent 
differences from that of normal tissue at multiple distances between the light source and 
detector.  Spectral patterns in diffuse reflectance spectra can be used for the 
discrimination of normal cervical tissue from low grade and high grade intraepithelial 
lesions. 
From 1999 to 2000, SpectRx’s Fiber Optical System and Camera System were 
introduced into a feasibility studies.  In 2001, a hybrid System of these was developed.  
Data collected from this device were used for algorithm development and a validation 
study.  As equivalence to hybrid system, Alpha and Beta prototype systems were 
developed during 2002-2006.  The pivotal trial data from this device were also used for 
algorithm validation.  
Spectrx, Inc collected 648 patients’ data in multicenter clinical trial.  The device 
collected data from 56 spatial points on the surface of the cervix for each patient. For 
each point, reflectance spectrum wavelength ranging from 410nm-700nm and 
florescence spectrum wavelength ranging from 400nm-700nm    was gathered.  The 
point level algorithms were developed based on approximately 30,000 observations and 
10,000 initial variables.  The whole cervix models were built from 648 observations and 
10,000 initial variables.  It should be noticed that we only use many fewer inputs to the 
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algorithm.  With the process of SpectRx pilot study, another 100 patients’ data are 
available for model prediction examination.   
At Georgia State University, three graduate students in statistics department have 
previously worked on the statistical analysis of the spectroscopic evaluation of cervical 
cancer. Wei Xu was first to compare the logistic regression models and CART models.  
In 2004, Kai Qu use cluster analysis to divide data into two parts then use partial least 
squares to classify both parts [7]. These results were compared with the one without using 
cluster analysis.  Two years later, Chenghong Shen reconsidered variables which were 
not used before, and adding more newly created variables to built models [8].  
This thesis is organized in the following order.  In chapter two, the data 
manipulation and variable selection procedure for point level analysis are first 
introduced, followed by logistic regression, cross-validation. Then the results from 
different approaches are compared and a conclusion is presented.  Chapter three is 
organized in the same way as previous chapter. The future studies are discussed in 
chapter four. 
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Chapter Two: Point Level Diagnosis 
 
One objective of the medical device is to create an image of the cervix that 
highlights the location and severity of disease.  Since the device collects data from 56 
spatial points on the surface of cervix, point level analysis of disease would help us to 
find the location of the disease and the patient diagnosis could be also conducted by 
combining all of the spatial information.  Furthermore, we would like to using point 
level diagnosis to render a cervix map that uses colors to represent the model output for 
each point.  Then a “weather map”- like image can be generated for each patient with the 
brighter areas corresponding to increased likelihood of disease. 
 
2.1 Data Manipulation and Variable Selection 
1.  Observations 
The training dataset contains 510 evaluable subjects. For each subject, there are 56 
records corresponding to 56 spatial points’ data.  Since some of the data points are 
excluded from the training dataset for various reasons, the total number of observations 
is around 20000.  However, these observations are not independent.  The approaches we 
used to create independent observations are discussed in the methodology section.  
(Table 2.1 provides the lookup table for excluding points) 
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Table 2.1 Lookup table for excluding points 
Artifact code Description 
0 No artifact 
1 Specular Reflection  
1.1 Possible Specular Reflection 
2 Mucus 
2.1 Possible Mucus 
3 Blood 
3.1 Possible Blood 
4 Non-Cervical Tissue 
4.1 Possibly Non-Cervical Tissue 
5 White Marking Dot 
5.1 Possibly White Marking Dot 
6 Bad Interrogation Point 
6.1 Possibly Bad Interrogation Point 
999 Other artifact 
 
2. Explanatory Variables 
The spectra data which contains all important explanatory variables are stored in 
an ASCII file for each patient.  It was composed of four spectrums: Reflectance 
spectrum; 340nm Fluorescence spectrum; 400nm Fluorescence spectrum; 460 
Fluorescence spectrum. The spectrum data format is described as following table: 
Table 2.2 Spectrum data structure in database 
Columns Description No. of wavelength elements
1 Point Number NA 
2-63 Reflectance Spectrum 62 
69-126 340nm Fluorescence Spectrum 58 
132-184 400nm Fluorescence Spectrum 53 
189-228 460nm Fluorescence Spectrum 40 
 
The initial number of explanatory variables is the sum of number of all 
wavelengths. These 213 initial variables was selected and reduced to 80 variables by 
  
6
applying following rules which was established by Previous research from Spectrx: 
1) Eliminate 400nm Fluorescence variables due to its little discriminating capability.  
2) Average 2 neighboring spectra variables. (also called 10nm binning) 
3) Divide the spectral variable by group mean. (also called self-normalization) 
 
3. Response Variable 
Biopsy conducted by pathologist and its result, histo-pathology, is considered as 
the gold standard.  SpectRx uses the pathology as the response variable for all models. 
Table 2.3 Pathology variable index 
0 Squamous Normal 
0.5 Transformation Zone 
1 Columnar Normal 
2 CIN 1 
2.5 CIN 1/2 
3 CIN 2 
3.2 CIN 2/3 
3.5 CIN 3+ 
9 Os 
-1 Unknown Classification 
999 Other Classification 
 
The points with pathology values equal to -1, 9, and 999 are not useful for our 
point diagnosis, so they need to be excluded first.  FDA stated that patient with 
pathology diagnosis as CIN1 or CIN1/2 can be classified as either disease or non-disease.  
So, in our model building process, CIN1 and CIN 1/2 are also excluded.  In order to 
create two distinct classes of disease, the cases were as positive for disease if the cases 
had pathology values greater than or equal to 3, while the non-disease were defined as a 
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pathology value less than 3.  
 
4. Data manipulation process 
     The data manipulation process of importing external file and variable creation are 
illustrated by the table below: 
Graph 2.1 Data manipulation process 
 
     ↓ 
 
 
           ↓ 
 
 
2.2 Methodology 
1. Observation independence  
As described in 2.1, since each patient has multiple spectral records which are 
correlated, treating each spectrum record as single observation is not practical.   
Independent observation could be created by reducing the variability between patients.  
Several approaches have been applied to reduce the correlation among the records 
within patient. 
It has been shown that the spectral intensity of a disease point is lower than non-
Import three spectrum data file from external 
ASCII data file into SAS 
Column positions in external file are 
2-63, 69-126, 189-226 
Self Normalization 
1) Average every two neighboring column 
in each group of spectrum 
2) Divide each of the above average value 
by its group mean 
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disease point at a low wavelengths.  For each patient, if we can subtract non-disease part 
from each record, then the newly-created record will not involve disease (or non-disease) 
variability between patients.  This problem therefore becomes to how to find the non-
disease part for each patient. 
From a biological perspective, squamous normal (SN), transformation zone (TZ) 
and columnar normal (CN) tissues can be treated as non-disease tissue.  We tried several 
combinations of normalization by looking at difference between SN, TZ and CN.  
However, this approach needs pre-knowledge of the position of these three types of 
normal tissues. 
As an alternative, using the assumption of normal tissues’ position is more 
practical.  It has been proved that cancer usually does not start on the peripheral region 
of the cervix.  Thus, each patient’s normal tissue can be found in the peripheral region.  
 
2. Model building 
Because our response variable is binary, which is either 1(disease) or 0(non-
disease), the multiple linear regression model is not appropriate for our data. Partial 
Least Squares and Logistic Regression [9], [10] can be used to accommodate binary data.     
Logistic regression analyzes binomially distributed data of the form Yi ~ B (pi, ni), 
for i=1, ... , m, where the numbers of Bernoulli trials ni are known and the probabilities 
of success pi are unknown. For each i, there is a k-vector Xi of known explanatory 
variables (independent variables or covariates). Thus 
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n
 =   
 
The logits of the unknown binomial probabilities (i.e., the logarithms of the odds) 
are modelled as a linear function of the Xi. 
1 1, ,log ( ) ln ...1
i
i i k k i
i
pit p x x
p
β β = = + + −   
Note that a particular element of Xi can be set to 1 for all i to yield an intercept in 
the model. The unknown parameters βj are usually estimated by maximum likelihood.  
The interpretation of the βj parameter estimates is the additive effect on the log odds 
ratio for a unit change in the jth explanatory variable. In the case of a dichotomous 
explanatory variable, for instance gender, eβ is the estimate of the odds ratio of having 
the outcome for, say, males compared with females.  The model has an equivalent 
formulation of: 
 
Extensions of the model exist to cope with multi-category dependent variables and 
ordinal dependent variables, such as polytomous regression. Multi-class classification by 
logistic regression is also known as multinomial logit modeling. An extension of the 
logistic model to sets of interdependent variables is the conditional random field. 
1 1, ,( ... )
1
1 i k k ii x x
p
e β β− + +
= +
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We use Proc Logistic and Proc PLS procedures in SAS package (Cary, NC) to 
build logistic and PLS models respectively and discovered the logistic models performed 
better than the PLS model for most criterion in our point level analysis.  The PLS 
approach is introduced in next chapter. 
 
3.  Assessing the fit of model 
An intuitively appealing way to summarize the results of a fitted logistic 
regression model is via a classification table.  This table is the result of cross-classifying 
the outcome variable, y , with a dichotomous variable whose values are derived from the 
estimated logistic probabilities. 
To obtain the derived dichotomous variable we must define a threshold (or 
cutpoint), c, and compare each estimated probability to c.  If the estimated probability 
exceeds c then we let the derived variable be equal to 1; otherwise it is equal to 0.  The 
appeal of this type of approach to model assessment comes from the close relationship 
of logistic regression to discriminate analysis when the distribution of the covariates is 
multivariate normal within the two outcome groups. 
The 2x2 classification table based on the logistics regression models in our study 
can be illustrate as below: 
Table 2.4 2x2 classification table 
Observed Classified 
Y=1 Y=0 
Total 
Y=1 a b a+b 
Y=0 c d c+d 
Total a+c b+d a+b+c+d 
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asensitivity
a c
= +          
dspecificity
b d
= +  
Sensitivity and specificity rely on a single cutpoint to classify a test result as 
positive.  A more complete description of classification accuracy is given by the area 
under the ROC (Receiver Operating Characteristic) curve.  This curve plots the 
probability of detecting true positive (sensitivity) and false negative (1-specificity) for an 
entire range of possible cutpoints. 
The area under the ROC curve, which ranges from zero to one, provides a 
measure of the model’s ability to discriminate between those subjects who experience 
the outcome of interest versus those who do not. 
     As a general rule, If ROC=0.5, a test shows no discrimination; If 0.7<ROC<0.8: 
this is considered acceptable discrimination; If 0.8<ROC<0.9: this is considered 
excellent discrimination; If ROC>0.9: this is considered outstanding discrimination. 
4. Model Validation 
Model validation is used to evaluate how well a model can be applied to any new data. 
We employed conventional cross-validation as well as K-folder cross-validation in the 
research.  The conventional cross-validation is to randomly split the data into two parts.  
We use 60/40, the larger part for training and the smaller for validation.  K-folder cross-
validation is a technique to train and validate data on the same dataset. In our study, we 
divided the training dataset into 10 approximately equal sized subsets.  Moreover, we 
ensure that patients with a certain Pap value are evenly allocated to each subset, 
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Therefore the 10 subsets are equivalent in size and content. The cross-validation process 
is then repeated 10 times, with each of the 10 sub samples used exactly once as the 
validation data. The 10 results from the folds then can be averaged (or otherwise 
combined) to produce a single estimation. 
 
2.3 Results and Conclusions 
      In our study, we go through data manipulation and a variable reduction process. The 
classification methodologies were then employed to find appropriate models. In the 
point level analysis, we focused on Logistic regression and Partial Least Squares 
Regression. The earlier study results for PLS and Logistic models are listed below. 
 Table 2.5 earlier study results of point level diagnosis 
 
We should notice that these models are ignoring the dependency of the 
observations. 
To get rid of variability between subjects, for each subject, we find the spectral 
value of mean of SN, TZ and CN points. (Denote by , ,SN TZ CNµ µ µ ).  Every subject has 
a SNµ , some subjects have TZµ , and some have CNµ . Then we take the difference SNµ  
with CNµ . (Denote by SN CNµ µ− ) If the subjects do not have CN points, take the 
Model No. of var AUC Train AUC Validation (10 
folder) 
Logistic full model 80 0.84416 0.79609 
Logistic stepwise model  NA 0.835577 0.80703 
PLS full model 80 0.83493 0.80009 
PLS reduced model 77 0.83378 0.79479 
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difference of SNµ  with. TZµ . (Denote by SN TZµ µ− ). Then, we subtract spectra values of 
each point from its  SN CNµ µ−  or SN TZµ µ− . 
Table 2.5 illustrates the one patient’s spectral data structure after the normalization 
process. 
 
 
Table 2.6 Normalized data structure (e.g. Patient 1001) 
We later discovered that patients trend to have much more SN tissue than TZ or 
CN tissue.  When the mean of SN, TZ and CN were taken respectively and followed by 
taking the difference of (CN-SN) or (TZ-SN), the weight of CN and TZ increase.  
Therefore, we treat CN, TZ as normal part is a solution. 
Table 2.7 Effectiveness of Normalization process --- Tissue Type 
Before 
Normalization 
Normal part for patient 1001 After Normalization Point 
Var1 … Var80 
Tissues 
type 
Var1 … Var80 Var1 Var80 
1 X1,1 … X1,80 SN X1,1- N1 X1,80- N80
2 X2,1 … X2,80 SN X2,1- N1 X2,80- N80
3 X3,1 … X3,80 TZ X3,1- N1 X3,80- N80
4 X4,1 … X4,80 SN X4,1- N1 X4,80- N80
5 X5,1 … X5,80 CN2 X5,1- N1 X5,80- N80
….. …… … …… …… …… …… 
56 X56,1 … X56,80 TZ 
 
N1=( X1,1+ 
X2,1+ 
X4,1)/3 – 
( X3,1+ 
X56,1)/2 
 
… 
 
N80=( X1,
80+X2,80+
X4,80)/3 – 
(X3,80+ 
X56,80)/2 
X56,1- N1 X56,80-N80
Model Normalization AUC Train AUC Validation 
Logistic full model (CN-SN) or (TZ-SN) 0.90288 0.82423 
PLS full model (CN-SN) or (TZ-SN) 0.88376 0.85027 
PLS reduced model (CN-SN) or (TZ-SN) 0.88377 0.85041 
Logistic full model TZ or CN 0.90683 0.85522 
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Comparing table 2.6 with 2.4, both training and validation AUC are improved.  
This provides evidence that normalization process is useful for our point level diagnosis. 
The major drawback of this approach is it has limit application for a new 
population, because it requires pre-knowledge of tissue type and the information about 
where these zones begin and end for new population, which is impractible.  
 
Graph 2.2 Cervix surface divided by peripheral vs central  
 
      
 
 
 
 
 
 
 
As mentioned previously, cancer almost never starts on the peripheral region of 
the cervix and its spectral value are usually small, we tried to find the normal part by 
taking the low percentiles combination (e.g. 5th, 10th, 25th, 50th) of the 20 peripheral 
locations’ spectral data.  Then we subtract these percentiles with spectrum data to get rid 
of the variability between subjects.  
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Table 2.8 Effectiveness of Normalization process --- Percentile 
 
 
 
 
 
      
 
Finding the “real” normal part can further improve above models.  The fixed 
twenty positions may not reflect the real peripheral locations, which depend on how the 
cervix images are taken.   
It was known that by identifying os location in cervix, the “true” central and 
peripheral group can be found.  It is also known that areas close to the os have a higher 
likelihood of disease than those that are distant. Using the RGB image to identify those 
points that are peripheral vs. those that are central may help. This because contrition in 
not always assured. As a first step toward this approach we will use Os locations already 
identified in the point level data set to see if this helps.  Use points neighboring the one 
marked 'Os' in the database as the central points and the remaining as peripheral.  
 
 
 
 
Percentile  AUC Train AUC Validation  
P5 0.83281 0.72989 
P10 0.81333 0.72322 
P25 0.82765 0.75890 
p50 0.80079 0.73381 
p75-p5 0.87156 0.76555 
p75-p10 0.87171 0.77955 
p75-p25 0.86258 0.77270 
p90-p5 0.87534 0.76521 
p90-p10 0.87891 0.78125 
p90-p25 0.85947 0.75531 
p95-p5 0.86837 0.74421 
p95-p10 0.87099 0.75372 
p95-p25 0.86444 0.75104 
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Table 2.9 Model performance comparison --- RGB image information 
 
 
 
 
 
 
 
 
 
Based on output indices from model (p90-p10), SpectRx engineers developed 
color maps.  The indices from logistic models range from 0 to 1, which represents 
probability of having cervical cancer or precancer.  Given a disease threshold, for model 
(p90-p10), 0.41, any index below 0.41 will be colored as dark, as number getting close 
to threshold, the color appears to be light. Above the threshold point are colored as white. 
Graph 2.3 Cervix surface color map  
 
         
Percentile  AUC Train AUC Validation  
P5 0.85410 0.74893 
P10 0.83922 0.71755 
P25 0.86288 0.76410 
p50 0.84781 0.76926 
p75-p5 0.87086 0.76861 
p75-p10 0.87857 0.77113 
p75-p25 0.87725 0.77385 
p90-p5 0.87787 0.77522 
p90-p10 0.88121 0.76224 
p90-p25 0.88210 0.77600 
p95-p5 0.87983 0.78031 
p95-p10 0.88276 0.76594 
p95-p25 0.88447 0.76647 
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The problem has to do with the approach of considering all points put together 
from all the subjects and then determining performance by the number of false negatives, 
false positives and so on. This compared to whole cervix performance where a true 
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positive occurs when, for example, only one point on the cervix of a person with disease 
needs to show up as positive. In other words, there can be many false negative points on 
the cervix but as long as we have one true positive we will be correct with this subject. 
This puts a very high performance demand on any point level algorithm. 
To illustrate this problem using Model (90-10), we have been able to get a 
performance of 95/60 sensitivity/specificity. The algorithm result was about 8,000 False 
Positives and 12,000 True Negatives. Thus specificity is 60% (TN/(TN+FP)).  However 
those 8,000 False Positives are distributed over almost all the subjects making it seem as 
if every subject has disease. Thus our whole cervix specificity is 0% and sensitivity 
100%.   It is clear that we must raise the threshold. This will make the performance on 
the "all points put together" population abysmal and obviate any "mapping for disease 
location" strategy. 
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Chapter Three: Diagnostic Methods 
 
     The color map is one approach for cervical cancer diagnosis.  However, it requires 
the model having extremely high discrimination of disease point from non-disease point 
for all 56 locations.  From subject level diagnosis perspective, it is not necessary to have 
all point level results.  Past researchers [8] have shown that the 25th percentile of the 56 
locations’ spectral data can best discriminate patients with CIN2 or higher.  In this 
chapter, we further examine the 25th percentile model and other previous models by 
applying to our current clinical trail data.  Since all pervious models [8] might use too 
many variables, which can cause overfit of the model and low prediction powers.  We 
conducted a thorough variable reduction process and the useful variable searching 
process is detailed in following sections. 
 
3.1 Data Manipulation and Variable Selection 
1.  Observations 
As we described in the previous chapter, for each subject, there are 56 records 
corresponding to 56 spatial points’ data.  In our subject level diagnosis, only one of the 
56 observations could be chosen to represent a patient’s disease status.  The early study 
showed that the 25th percentile is most useful data for discrimination.   Besides the 510 
subject’s data in SpectRx early clinical trail, we add more clinical trial data (e.g. dallas 
dataset, pilot alpha dataset, pilot beta dataset) to test model prediction. 
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2. Explanatory Variables 
In SpectRx’s early study, for all 78 spectral wavelengths, the 25th percentile was 
chosen to create 78 explanatory variables.  Our recent research indicates that lower 
percentiles, such as 10th, 25th, are useful for discrimination for lower wavelengths of 
spectrum data; while the higher percentiles, such as 75th, 90th, contains discrimination 
information in the higher wavelengths of spectral data.  Thus we extend 78 explanatory 
variables to 312 variables.  This trend can be illustrated by the graphs which were 
produced by a SpectRx engineer.   
Graph 3.1 Mean of P25 spectra for 522 Training subjects 
Reflectance Spectrum  
       
 
   
 
 
 
 
 
 
 
340 nm Fluorescence  
Spectrum 
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460nm Fluorescence  
Spectrum  
 
 
 
 
 
 
 
Graph 3.2 Mean of P75 spectra for 522 Training subjects 
Reflectance Spectrum  
 
 
 
 
340 nm Fluorescence 
Spectrum 
 
 
 
 
 
 
 
460nm Fluorescence  
Spectrum 
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Following observations and conclusions may be made: 
? We notice that at wavelengths below 590 nm spectra  (blue wavelengths) diseased 
tissue has a lower intensity than normal tissue  
? On the other hand, for wavelengths above 590 nm spectra (red wavelengths) 
diseased tissue has higher intensity than normal tissue 
? At a lower percentile, 25th percentile for example, we would select spectra from 
diseased tissue (when present) 
? The higher percentiles are better discriminator for red wavelengths.  
? The higher percentiles are not as good as lower percentiles for selecting disease 
tissue 
     Table 3.1 summarizes these trends. 
Table 3.1 Variable flip index 
 Blue Flip Red 
Reflectance (wavelength in nm) 410 590 690 
Reflectance (wavelength variable) 1 19 29 
Fluorescence 340 ex (wavelength in nm) 410 490 690 
Fluorescence 340 ex (wavelength variable) 30 38 58 
Fluorescence 460 ex (wavelength in nm) 500 590 690 
Fluorescence 460 ex (wavelength variable) 59 68 78 
To verify these findings in quantitative way, we conducted several mean 
comparison tests, including Wilcoxon test and t test.  These tests were conducted as 
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follows: within certain variables, observations are grouped by their pathology test results.  
Two groups are formed: cancer vs non-cancer.  Calculate a score (t-statistic / wilcoxon 
rank statistic) for each variable.  We ranked the 312 scores to find 312 variables’ 
discrimination power.  We finally reduced the simple explanatory variable number to 15 
in the variable pre-selection.    
     We also discovered that taking the ratio between two simple variables increases 
discrimination.  For the 510 subject training data set, using the 78 spectral variables, we 
created 78x78=6084 variables where each variable was divided by itself and the 
remaining 77 variables and so on.  Then we generated ROC curves and from these pick 
the highest specificity obtained at 95% sensitivity or above.   
     Graph 3.3 showed color plots where the color coded specificities are shown for each 
of p10, p25, p50 and p75 aggregate vectors. 
Graph 3.3 ratio variable specificity performances under 95% sensitivity 
1. P10  
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2. P25 
 
 
3. P50 
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4. P75 
 
 
 
In addition to spectral data, other test results, such as the Pap smear result 
(cytology), are collected. The pap test is microscopic examination of cells from the 
cervix.  It is primarily designed to detect changes that may be cancerous or may lead to 
cancer.  It may also detect infections and abnormalities.  Because this information is 
available and may add information independent from the spectral variables, we can 
include it in the model. 
Table 3.2 Pap variable index 
0 Normal 
1 Benign Changes 
2 ASCUS, not favoring neoplasia 
2.8 ASCUS, favor neoplasia 
3 LSIL 
3.2 AGUS 
 
 
2. Response Variable 
The biopsy conducted by pathologist and its result, pathology, is considered as the 
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gold standard.  SpectRx uses the pathology as the response variable for all models. 
Table 3.3 Pathology variable index 
0 Normal 
1 Non-dysplastic change 
2 CIN 1 
2.5 CIN 1/2 
3 CIN 2 
3.2 CIN 2/3 
3.5 CIN 3+ 
 
Patients with a pathology diagnosis as CIN1 or CIN1/2 can be regarded as either 
disease or non-disease.  So, in our model building process, CIN1 and CIN 1/2 are 
excluded.  The disease cases are defined as pathology value greater than or equal to 3, 
while the non-disease are pathology value less or equal to 1.  
 
3.2 Methodology 
Partial Least Squares (PLS) is a method for constructing predictive models when 
factors are many and highly collinear [11], [12].  PLS balances objectives of explaining 
response variation and explaining predictor variation.  A PLS model can be shown as  
1 1 2 2 3 3 ... ,n n nY t q t q t q t q E= + + + + +   
Where t are the latent variables or scores; q are the loading vectors. 
     Note that the scores are chosen so that the relationship between successive pairs of 
scores is as strong as possible.  In general, PLS is finding a linear combination of 
variables [13].  It can be shown that PLS seeks directions that have high variance and high 
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correlation with the response in contrast to principal components.  In particular, the mth 
principal component direction mv  solves: 
1
0, 1,.., 1
var( )max
T
lv s l m
X
α
α
α
=
= = −
, 
Where S is the sample covariance matrix of xj.  The conditions 0Tlv sα =  ensures 
that mz Xα=  is uncorrelated with all the previous linear combinations l lz Xv= . The 
mth PLS direction mϑ∧  solves: 
2
1
0, 1,.., 1
( , ) ( )max
T
l s l m
Corr y X Var X
α
ϑ α
α α
∧
=
= = −
 
 
We calculated Area Under Curve (AUC), sensitivity and specificity to evaluate 
model performance.  It is observed that model performance in terms of AUC is closely 
related to the number of variables and the variables chosen.  Model can be built based on 
AUC criterion [14], but it was found to be asymptotically equivalent to stepwise 
regression.  Therefore, we have to adopt both statistical methods and non-statistical 
(manual) methods in variable selection. 
We evaluate our models by following criteria described as below: 
a Best specificity at 99/95/90 sensitivity levels will be evaluated.   
b Models should give sensitivity that does not vary more than +/- 5 percentage points 
when the same threshold is applied to all data sets. 
c The same PAP test scaling must be used in conjunction with criterion (b) above 
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when determining performance with PAP. 
d The model should meet a minimum performance benchmark for each Pap category 
across all data sets. 
e The candidate model will have the least shrinkage upon 10 folder cross validation 
 
3.3 Results and Conclusion 
     With mean comparison test and trends we found in graph 3.1 and 3.2, we are able to 
select the most useful covariates.  In this process, we tried to reduce the number of 
original 80 variables as much as possible.  
Table 3.4 Variable Reduction Performance 
Variables Training AUC  Validation AUC
p10: 1-4 30-33  p25: 30-33  mean: 30-33  p75: 27-33 0.72619 0.70668 
p10: 30-33     p25: 30-33  mean: 30-33   p75: 30-33 0.72107 0.68435 
p25: 1-5 30-33 0.72599 0.71246 
p25: 30-33  p75: 71-78 0.74480 0.70668 
p75: 25-31 0.70245 0.76849 
p25: 30-33 0.72599 0.70349 
p25: 1-5 30-33 59-63 0.75633 0.71466 
Model 2.0: p25: 1-5 30-32  p75: 25-31 0.74549 0.73141 
Fan’s Model 1: p25 1-80 0.84832  0.74696 
Model 2.0 + pap 0.83346 0.82667 
Fan’s Model 1 + pap 0.90558 0.81373 
 
     Compared with SpectRx former model (model1.0), the number of variables in Model 
2.0 reduced from 80 to 15, while it has only 1 percent AUC shrinkage.  These 15 
variables’ performances are consistent in adding pap covariate.  
     In addition to simple percentile variables, we investigated the effectiveness of ratio 
variables which are defined in explanatory variables, section 3.1.  We examine 
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individual ratio variables performance which provided in graph 3.3.  In the graph, 
variables falls in the lightest color area are most potentially useful.  Their discriminative 
ability is ranked by Wilcoxon statistics.  
Table 3.5 Wilcoxon Rank for Ratio Variables 
variable Wilcoxon Statistics 
f125r30v45 6.91 
f125r30v48 6.84 
f125r30v46 6.79 
f125r30v49 6.77 
f125r31v45 6.76 
f125r30v50 6.75 
f125r30v47 6.75 
f175r30v50 6.75 
f110r30v45 6.70 
f175r30v49 6.69 
f125r30v51 6.67 
f150r30v48 6.66 
f175r31v50 6.65 
f150r30v45 6.63 
f150r30v50 6.63 
f175r31v49 6.62 
f110r30v46 6.61 
f150r30v49 6.61 
f110r31v45 6.60 
f175r30v48 6.60 
f110r30v47 6.59 
f110r30v48 6.58 
f125r31v48 6.58 
f175r31v48 6.58 
Note: f125r30v45 ratio variable represents variable 30 at 25th percentile (of 56 locations) 
divided by variable 45 at 25th percentile. 
     By combining simple variables with ratio variables, we were able to form several 
variable combinations to place into PLS regression.  These models, with SpectRx 
previous models (model 1.0, 2, Mixed 1.5, Mixed 1.9) were evaluated for their 
specificities under 99/95/90 present sensitivity levels.  Dallas dataset and pilot datasets 
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are used to validate model prediction on new populations. 
Table 3.6 Model performance comparison chart I 
Specificity at 90% Sensitivity 
 510 
trainin
g 
62 
case
s 
 
Dallas
 
Dallas 
2 
Pilot 
Beta1/Beta2 
Equiv
Alpha
Model 1.0 50 4 22 55 24 13 8 
Model 1.1 50 42 28 61 27 17 12 
Hailun 15 Coeff Model 47 0 13 23 28 25 16 
Chenghong Mixed Model 
1.5 
58 50 20 29 12 9 12 
Chenghong Mixed Model 
1.9 
58 42 15 52 16 9 8 
Model 2.3: 15 simple+11 
ratio 
47 13 23 23 24 29 40 
Mixed percentile (p25+p75) 58 25 28 52 20 4 4 
Mixed percentile (p25+p90) 55 67 33 52 20 25 12 
New ratio 1+15 coeff model 52   36   28 
New ratio 2+15 coeff model 52   23   28 
New ratio 3+15 coeff model 48   36   44 
New ratio 4+15 coeff model 48   29   40 
Mark F+ 15 + mix model 61  22  36 9 56 
Mark F+ 15 + reduce mix 
model 
40  30  32 26 48 
New1 MarkF(p25/p75)+15 52  12  40 13 28 
New2 Mark F (p25/p90)+ 
15 
55  15  36 17 36 
 
Specificity at 95% Sensitivity 
 510 
trainin
g 
62 
case
s 
Dallas Dallas 
2 
Pilot 
Beta1/Beta2 
Equiv 
Alpha 
Model 1.0 37 N/A 21 N/A N/A N/A N/A 
Model 1.1 41 N/A 28 N/A N/A N/A N/A 
Hailun 15 Coeff Model 36 N/A 11 N/A N/A N/A N/A 
Chenghong Mixed Model 
1.5 
38 N/A 17 N/A N/A N/A N/A 
Chenghong Mixed Model 
1.9 
38 N/A 13 N/A N/A N/A N/A 
Model 2.3: 15 simple+11 41 N/A 17 N/A N/A N/A N/A 
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ratio 
Mixed percentile (p25+p75) 44 N/A 27 N/A N/A N/A N/A 
Mixed percentile (p25+p90) 45 N/A 23 N/A N/A N/A N/A 
New ratio 1+15 coeff model 32   N/A   N/A 
New ratio 2+15 coeff model 34   N/A   N/A 
New ratio 3+15 coeff model 29   N/A   N/A 
New ratio 4+15 coeff model 27   N/A   N/A 
Mark F+ 15 + mix model 45  22  N/A N/A N/A 
Mark F+ 15 + reduce mix 
model 
29  18  N/A N/A N/A 
New Mark F (p25/p75)  + 
15  
40  10  N/A N/A N/A 
New2 Mark F (p25/p90) + 
15  
46  10  N/A N/A N/A 
 
Specificity at 99% Sensitivity 
 510 
trainin
g 
62 
case
s 
Dallas Dallas 
2 
Pilot 
Beta1/Beta2 
Equiv 
Alpha 
Model 1.0 20 4 20 32 4 13 8 
Model 1.1 15 42 28 29 12 13 8 
Hailun 15 Coeff Model 16 0 2 3 28 0 8 
Chenghong Mixed Model 
1.5 
17 21 15 26 0 9 4 
Chenghong Mixed Model 
1.9 
27 25 12 19 8 9 8 
Model 2.3: 15 simple+11 
ratio 
24 8 5 10 23 8 32 
Mixed percentile (p25+p75) 18 8 17 32 4 0 4 
Mixed percentile (p25+p90) 9 4 8 16 4 0 12 
New ratio 1+15 coeff model 16   13   20 
New ratio 2+15 coeff model 20   13   28 
New ratio 3+15 coeff model 16   6   16 
New ratio 4+15 coeff model 17   19   32 
Mark F+ 15 + mix model 20  12  0 4 0 
Mark F+ 15 + reduce mix 
model 
22  5  28 9 4 
New Mark F (p25/p75)  + 
15  
7  2  20 0 16 
New2 Mark F (p25/p90) + 
15  
17  5  32 0 24 
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     From this performance chart, we find model 2.3 is the best candidate model, not only 
because of its reasonable performance on our training dataset, but also its high 
specificity for new datasets, especially for pilot data. 
     To complete the classification analysis, we include CIN1, CIN1/2 cases to our study.  
Model 2.31 has same covariates as 2.3, but with CIN1 and CIN1/2 cased in.  The Model 
has little shrinkage under 10 folder cross validation. 
Table 3.7 Model performance comparison chart II 
Specificity at 90% Sensitivity 
 510 
training
62 
cases
 
Dallas
 
Dallas 
2 
Pilot 
Beta1/Beta2 
Equiv 
Alpha 
Model 2.3 38/48 11/8 23/23 20/23 24/24 29/29 36/40 
Model 2.31 37/48 21/21 27/27 32/39 31/28 27/33 33/44 
Model 2.31 (validation) 37/48 21/21 27/27 38/39 31/28 27/33 33/44 
 
Specificity at 95% Sensitivity 
 510 
training
62 
cases
 
Dallas
 
Dallas 
2 
Pilot 
Beta1/Beta2 
Equiv 
Alpha 
Model 2.3 16/21 9/8 3/5 8/10 20/23 6/8 30/32 
Model 2.31 22/31 9/4 4/10 5/0 19/24 6/8 28/36 
Model 2.31 (validation) 22/31 9/4 4/10 5/0 19/24 6/8 28/36 
     Adding pap categories to model 2.3 using a decision tree method, we obtained a 
common threshold at -0.05 across all data sets.  For model 2.3 itself, the common 
threshold for all datasets is also obtained at 0.08. 
Table 3.8 Model performance comparison chart III 
Model 2.3 
Data Set Sensitivity Specificity 
510 99% 18% 
Dallas all 94% 26% 
Equivalence alpha  100% 32% 
Equivalence beta1 100% 24% 
Equivalence beta2 92% 21% 
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Model 2.3 + pap 
Data Set Sensitivity Specificity 
510 132/133  (99%) 64/226  (29%) 
Dallas2 9/10   (90%) 16/31   (52%) 
Dallas all 16/17   (94%)    20/60   (33%) 
Equivalence alpha      12/12   (100%) 8/25   (32%) 
Equivalence beta1     12/12   (100%) 6/25   (24%) 
Equivalence beta2     11/12   (92%)     5/23   (22%) 
Total    192/195  (98.5%)   119/392  (30%) 
 
     In order to further reduce the variables in model 2.3, we did variable selection based 
on significance and correlation tests.  The results are listed in table 3.9. 
Table 3.9 Model performance comparison chart IV 
90% 95% 99%     
510 Alpha Beta 510 Alpha Beta 510  Alpha Beta
Model 2.3 (26 var) 47 46 28 41 46 NA 21 4 24 
Model 2.37 (20 var) 50 48 28 37 41 NA 23 2 24 
Model 2.38 (20var) 49 46 32 40 43 NA 25 2 28 
Model 2.39 (20 var) 48 32 28 29 30 NA 20 2 28 
Model 2.40(21 var) 50 39 24 45 29 NA 24 NA 24 
Model 2.41(13 var) 42 11 16 35 7 NA 23 7 0 
Model 2.42(18 var) 45 11 16 37 7 NA 23 7 0 
Model 2.43(25 var) 42 11 20 29 7 NA 16 0 12 
     Note that Model 2.37 has 6 less variables than 2.3, but its performance is quite 
competitive.  We compared them at common thresholds across all datasets. 
 
Table 3.10 Model performance comparison chart V 
 Model 2.3 at threshold 0.105 Model 2.37 at threshold 0.115 
510 98.5 / 19 98.5 / 21 
Alpha pick 95.5 / 46.4 95.5 / 41 
Beta pick 100 / 24 91.7 / 28 
Inspired by the color graph 3.3, we explored the ratio variable by this rule: the 
numerators (minimum) were always chosen from blue wavelengths and denominators 
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(maximum) from red (see table 3.1).  To be consistent with biological theory, when 
mixed ratios are used the numerators are from the lower percentile and denominator 
from the higher percentile.  The threshold for choosing variables was a minimum of 25% 
specificity at 95% sensitivity.  When this threshold was raised to 30% the ratio groups 
highlighted in yellow survived although not all individual variables in that group.  The 
ratios highlighted in red are unstable because they are too close to the flip point (from 
red to blue) wavelengths. 
Table 3.11 Ratio Variables List 
P10 (31,32)/(41-43) (33,34)/(37,38)    
P25 (30,31)/(21,22) (30,31)/(50-56)    
P50 (30,31)/(50-56)     
P75 (30-32)/(47-58) (30-32)/(75-78)    
P90 (30-32)/(47-58)     
P10_75 (30-32)/(49-57) (30,31)/(75-78) (33,34)/(37,38) (61-66)/(41-43) (62-64)/(46-48) 
P10_90 (30-32)/(21-29) (30,31)/(49-51) (30-32)/(70-78) (33,34)/(37,38)  
P25_75 (30-32)/(21-29) (30,31)/(46-57) (30,31)/(71-78) (64-66)/(42,43) (61-64)/(46-48) 
P25_90 (30-32)/(21-29) (30-32)/(49-57) (30-32)/(69-78)   
     There are a total of 22 cells, excluding 3 red cells.  Each ratio variable can be created 
by applying a min/max rule which is effective in reducing the correlation among 
adjacent variables.  For example, ratio var1 = min of (31, 32) / max of (41-43).  
Applying this rule, we built four new models with new ratio variables.  Notice that 
Model 2.45: 22 min/max variables; Model 2.46: 15 single variables + 22 min/max; 
Model 2.47: reduced 2.45 to 11 vars; Model 2.48: 15 single var + 11 min/max. Table 
3.10 shows that model 2.46 has best performance at 99% sensitivity levels for both 510 
and pilot data.   
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Table 3.12 Model performance comparison chart VI 
90% 95% 99%     
510 Alpha Beta 510 Alpha Beta 510  Alpha Beta
Model 2.45 51 30 20 37 21 NA 20 21 4 
Model 2.46 50 23 24 38 23 NA 25 20 20 
Model 2.47 44 25 16 24 16 NA 18 13 16 
Model 2.48 53 23 32 27 18 NA 18 11 32 
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Chapter Four: Future Study 
 
     One purpose of our point level analysis was to combine all diagnostic results of all 56 
cervical surface locations to provide index for each subject.  Thus, we have more 
information for patient level diagnosis. For each individual, once we have the 56 point 
indices which represent probabilities of having disease, the combination of these points 
may provide information for patient level diagnosis. Logistic algorithm and PLS 
algorithm could be adopted to find out relationship between point diagnosis and patient 
level diagnosis.  Some work has been done by using point level models (p90-p10). 
1. Point output indices from the point level model (AUC: 0.88(T) 0.78(V)) with Os 
location,  totally are 273 subjects (no CIN1) and 56 variables(points), apply PLS 
algorithm:  
     10-folder AUC performance:  
                                                     Train             Validation  
                 56 variables                   0.725               0.714  
           56 variables + pap                0.888               0.834  
2. Point output indices from the point level model (AUC: 0.88(T) 0.78(V)) with fixed 
20 peripheral location, totally are 347 subjects (no CIN1) and 56 variables(points), 
apply PLS algorithm: 
      
     10-folder AUC performance:  
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                                                     Train             Validation  
                 56 variables                   0.633               0.624  
           56 variables + pap                0.865               0.801  
Compared with the models in chapter three, this approach did not improve AUC. 
One of the reasons might be that 28% points are missing which results in insufficient 
information for running PLS regression.  To improve this, a simulation might be 
involved to solve the missing data problem.  Since we have the point position 
information, once we have some point indices, their adjacent point having missing 
values might be simulated by some approximation methods. 
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APPENDIX I: SAS CODE FOR INITIAL DATA MANIPULATION, VARIABLE 
REDUCTION IN POINT ANALYSIS 
/* This is a program to manipulate data for point analysis  
 
  file: point_analysis_mani.sas 
  created by: Chenghong Shen 
  modified by: Hailun Wang 
  last update: 06/22/2006 
 
*/ 
 
%include 'K:\intern\spectrx\fan\missing_mac.sas'; 
libname After 'K:\intern\spectrx\PointAnalysis\'; 
 
options nonotes; 
options nonumber nodate;  
 
data After.R; 
 set _null_; 
run; 
 
%macro getpointdata(path1 = , path2 = , path3 = , path4 = , path5 = ,  
        file = , spacing = 10, dataout =,  
  subselect = 1, pointselect = 0, disq = no, extype = manual, spectype = 
orig, 
  /*sub_id=, point_start=, point_end=, reflec=, fluore1=, fluore2=, 
fluore3=*/); 
 
 data demo; 
 infile "&path1&file" expandtabs lrecl = 10000 missover; 
    input sub_id$ available unclean datec$ whole1 sitepath qa1 PriorPap PriorPaptype 
  DayofPap DayofPaptype PreferredPap PreferredPaptype scjvisible 
colpoadequacy Age Race 
  menstrual Menopause Gravida Para Abort Birthcontrol Priorsurgery1 
DaysPriorsurgery1 
  Priorsurgery2 DaysPriorsurgery2 Priorsurgery3 DaysPriorsurgery3  
  Priorsurgery4 DaysPriorsurgery4 Priorsurgery5 DaysPriorsurgery5 height 
weight  
  smoking Cigarettesperday; 
 d_id = substr(sub_id, 1, 1); 
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 year = substr(datec, 1, 4); month = substr(datec, 5, 2); day = substr(datec, 7, 2); 
 date = mdy(month, day, year); 
 %nmissing(varlist = available unclean whole1 sitepath qa1 PriorPap 
PriorPaptype 
  DayofPap DayofPaptype PreferredPap PreferredPaptype scjvisible 
colpoadequacy Age Race 
  menstrual Menopause Gravida Para Abort Birthcontrol Priorsurgery1 
DaysPriorsurgery1 
  Priorsurgery2 DaysPriorsurgery2 Priorsurgery3 DaysPriorsurgery3  
  Priorsurgery4 DaysPriorsurgery4 Priorsurgery5 DaysPriorsurgery5 height 
weight  
  smoking Cigarettesperday, missing = -1 -2); 
 if available and &subselect; 
 run; 
 
 proc sort data = demo; by sub_id; run; 
 
 data _null_; set demo end = last; 
    call symput('sub'||left(_n_), trim(left(sub_id))); 
    if last then call symput('nsub', _n_);   
 run; 
 
 proc sort data = demo; by sub_id; run; 
 
 data coordinates; 
 infile 
'k:\intern\spectrx\fan\nci\hybrid\data3\HybridInterrogationPointCoordsmm.txt' 
expandtabs; 
 input point x y; 
 run; 
 
 %do i = 1 %to &nsub; 
  %put Read Data File For Subject #&i out of %left(&nsub) &&sub&i; 
 
  /* Read the point analysis data */ 
 
  %if %sysfunc(fileexist("&path4.&&sub&i.._pointgold.txt")) %then %do; 
  data pointgold; 
    
 infile "&path4.&&sub&i.._pointgold.txt" expandtabs lrecl = 100000; 
 input point pathology1 pathology2; 
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    if pathology1>pathology2 then pathology=pathology1; 
 else pathology=pathology2; 
  
 if pathology=0.5 then pathology=0; 
 
 drop pathology1 pathology2; 
 
  run; 
   
   
  data pointcat; 
 infile "&path3.&&sub&i.._excl_&extype..txt" expandtabs; 
 input point reject; 
  run; 
 
  Data org; 
    
 INFILE "&path2.&&sub&i.._spectra_autopeakrowdetect_notiszero2.txt" 
expandtabs lrecl = 100000; 
   
 input point rf_1-rf_63 b1-b4 f1_1-f1_59 b5-b8 f2_1-f2_53 b9-b12 f3_1-f3_41; 
 array rf rf_1-rf_63; array f1 f1_1-f1_59; array f2 f2_1-f2_53; array f3 f3_1-f3_41; 
   
  
 %spacingselfnorm; 
 sub_id = "&&sub&i"; 
    
 
  run; 
   
  data org_merge; 
 merge org pointgold pointcat; 
 *if reject in (&pointselect); 
 by point; 
  run; 
 
  
   
  data After.R; 
  set After.R org_merge; 
  run; 
%end;  
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%end; 
 
 
%mend; 
 
 
%macro spacingselfnorm; 
 %let t1 = 31; %let t2 = 29; %let t3 = 26; %let t4 = 20;  
    array nrf nrf_1-nrf_&t1; array nf1 nf1_1-nf1_&t2; array nf2 nf2_1-nf2_&t3; array nf3 
nf3_1-nf3_&t4; 
 array rnrf rnrf_1-rnrf_&t1; array rnf1 rnf1_1-rnf1_&t2; array rnf2 rnf2_1-
rnf2_&t3; array rnf3 rnf3_1-rnf3_&t4; 
 
 %if &spacing = 5 %then %do; 
  do i = 1 to &t1; nrf(i) = rf(i); end; 
  do i = 1 to &t2; nf1(i) = f1(i); end; 
  do i = 1 to &t3; nf2(i) = f2(i); end; 
  do i = 1 to &t4; nf3(i) = f3(i); end; 
 %end; 
 %else %if &spacing = 10 %then %do; 
  do i = 1 to &t1; nrf(i) = (rf(2 * i - 1) + rf(2 * i)) / 2; end; 
  do i = 1 to &t2; nf1(i) = (f1(2 * i - 1) + f1(2 * i)) / 2; end; 
  do i = 1 to &t3; nf2(i) = (f2(2 * i - 1) + f2(2 * i)) / 2; end; 
  do i = 1 to &t4; nf3(i) = (f3(2 * i - 1) + f3(2 * i)) / 2; end; 
 %end; 
 %else %do; 
  do i = 1 to &t1; nrf(i) = (rf(4 * i - 3) + rf(4 * i - 2) + rf(4 * i - 1) + rf(4 * i)) 
/ 4; end; 
  do i = 1 to &t2; nf1(i) = (f1(4 * i - 3) + f1(4 * i - 2) + f1(4 * i - 1) + f1(4 * 
i)) / 4; end; 
  do i = 1 to &t3; nf2(i) = (f2(4 * i - 3) + f2(4 * i - 2) + f2(4 * i - 1) + f2(4 * 
i)) / 4; end; 
  do i = 1 to &t4; nf3(i) = (f3(4 * i - 3) + f3(4 * i - 2) + f3(4 * i - 1) + f3(4 * 
i)) / 4; end; 
 %end; 
 
  
 avgnrf = mean(of nrf_1-nrf_&t1); stdnrf = std(of nrf_1-nrf_&t1); 
 avgnf1 = mean(of nf1_1-nf1_&t2); stdnf1 = std(of nf1_1-nf1_&t4); 
 avgnf2 = mean(of nf2_1-nf2_&t3); stdnf2 = std(of nf2_1-nf2_&t4); 
 avgnf3 = mean(of nf3_1-nf3_&t4); stdnf3 = std(of nf3_1-nf3_&t4); 
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 do i = 1 to &t1; rnrf(i) = (nrf(i) / avgnrf); end; 
 do i = 1 to &t2; rnf1(i) = (nf1(i) / avgnf1); end; 
 do i = 1 to &t3; rnf2(i) = (nf2(i) / avgnf2); end; 
 do i = 1 to &t4; rnf3(i) = (nf3(i) / avgnf3); end;  
 
  
%mend; 
 
 
 
%getpointdata(path1 = k:\intern\spectrx\fan\Aftertrain\,  
     
    /* Data for training  */ 
    path2 = k:\intern\spectrx\workdir\DATA\, 
    path3 = k:\intern\spectrx\workdir\manual\,  
 path4 = k:\intern\spectrx\workdir\point_analysis\, 
 path5 = k:\intern\spectrx\workdir\graph\,  
    /*sub_id =4124, 
    point_start =29, 
 point_end =33, 
 reflec =1, 
 fluore1 =1, 
 fluore2 =1, 
 fluore3 =1, */ 
 
    file = HybridFINAL_ClinicalData_dm_2.txt, spacing = 10, dataout = All, disq = yes, 
    subselect = (unclean = 0 and whole1~= .)); 
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APPENDIX II: SAS CODE FOR CREATING NEW VARIABLES IN POINT 
ANALYSIS USING TISSUE TYPE 
 
/* This is the point data manipulation, treating the range of values between normal types 
of tissue in each subject as index to get rid of variability between subjects 
file: test_point_model2.1_new_mani 
Created by: Hailun Wang 
Last update: 06/22/06*/ 
 
 
libname After 'k:\intern\spectrx\pointAnalysis'; 
option nodate nonotes; 
data SN; 
  set After.M; 
  if pathology in (0); 
run; 
 
data CN; 
  set After.M; 
  if pathology in (1); 
run; 
 
data TZ; 
  set After.M; 
  if pathology in (0.5); 
run; 
 
proc means data=SN noprint; 
  var nrf_1-nrf_31 nf1_1-nf1_29 nf3_1-nf3_20; 
  by sub_id; 
  output out=SN_mean  
  mean=x1-x31 y1-y29 z1-z20; 
run; 
 
proc means data=CN noprint; 
  var nrf_1-nrf_31 nf1_1-nf1_29 nf3_1-nf3_20; 
  by sub_id; 
  output out=CN_mean  
  mean=m1-m31 n1-n29 k1-k20; 
run; 
 
proc means data=TZ noprint; 
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  var nrf_1-nrf_31 nf1_1-nf1_29 nf3_1-nf3_20; 
  by sub_id; 
  output out=TZ_mean  
  mean=a1-a31 b1-b29 c1-c20; 
run; 
 
data SNandCN; 
  merge SN_mean CN_mean; 
  by sub_id; 
  if m1=. or x1=. then delete; 
run; 
 
data SNremain; 
  merge SN_mean CN_mean; 
  by sub_id; 
  if m1 not in(.) then delete; 
  drop m1-m31 n1-n29 k1-k20; 
run; 
 
 
data SNandTZ; 
  merge SNremain TZ_mean; 
  by sub_id; 
  if x1=. or a1=. then delete; 
run; 
 
data normalization1; 
  set SNandCN; 
    %macro norm; 
      %do i=1 %to 31; 
        norm1_&i=m&i-x&i; 
      %end; 
      %do j=1 %to 29; 
        norm2_&j=n&j-y&j; 
      %end; 
      %do h=1 %to 20; 
        norm3_&h=k&h-z&h; 
      %end; 
    %mend; 
    %norm; 
run; 
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data normalization2; 
  set SNandTZ; 
    %macro norm; 
      %do i=1 %to 31; 
        norm1_&i=a&i-x&i; 
      %end; 
      %do j=1 %to 29; 
        norm2_&j=b&j-y&j; 
      %end; 
      %do h=1 %to 20; 
        norm3_&h=c&h-z&h; 
      %end; 
    %mend; 
    %norm; 
run; 
 
data normalization; 
  set normalization1 normalization2; 
run; 
 
proc sort data=After.M; 
  by sub_id point; 
run; 
proc sort data=normalization; 
  by sub_id; 
run; 
data mix; 
  merge After.M normalization; 
  by sub_id; 
  if x1=. then delete; 
run; 
 
data point_train; 
  set mix; 
  %macro group; 
    %do i=1 %to 31; 
      diff1_&i=nrf_&i-norm1_&i; 
    %end; 
    %do j=1 %to 29; 
      diff2_&j=nf1_&j-norm1_&j; 
    %end; 
    %do k=1 %to 20; 
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      diff3_&k=nf3_&k-norm1_&k; 
    %end; 
  %mend; 
  %group; 
run; 
 
data After.point_diff4; 
  set point_train (keep=sub_id point pathology reject diff1_1-diff1_31 diff2_1-diff2_29 
diff3_1-diff3_20); 
run; 
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APPENDIX III: SAS CODE FOR CREATING NEW VARIABLES IN POINT 
ANALYSIS USING PERCENTILES IN PERIPHERAL GROUP 
 
/* this is the point data manipulation, treating the difference between different 
percentiles in peripheral area in each subject as index to get rid of variability between 
subjects 
file: test_point_model1.3(2)_new_mani 
Created by: Hailun Wang 
Last update: 06/25/06*/ 
 
libname After 'k:\intern\spectrx\pointAnalysis'; 
 
data Peripheral; 
  set After.M; 
  where point in (1 2 3 4 5 11 12 19 20 28 29 37 38 45 46 52 53 54 55 56); 
run; 
 
proc means data=Peripheral noprint; 
  var rnrf_1-rnrf_31 rnf1_1-rnf1_29 rnf3_1-rnf3_20; 
  by sub_id; 
  output out=peripheral_mean  
  p10=a1-a31 b1-b29 c1-c20 
  p90=d1-d31 e1-e29 f1-f20; 
run; 
 
data peripheral_mean; 
  set peripheral_mean; 
  %macro normal; 
    %do i=1 %to 31; 
      x&i=d&i-a&i; 
    %end; 
    %do j=1 %to 29; 
      y&j=e&j-b&j; 
    %end; 
    %do k=1 %to 20; 
     z&k=f&k-c&k; 
    %end; 
  %mend; 
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%normal; 
run; 
 
proc sort data=After.M; 
  by sub_id point; 
run; 
 
proc sort data=peripheral_mean; 
  by sub_id; 
run; 
 
data mix; 
  merge After.M peripheral_mean; 
  by sub_id; 
run; 
 
data point_train; 
  set mix; 
  %macro group; 
    %do i=1 %to 31; 
      diff1_&i=rnrf_&i-x&i; 
    %end; 
    %do j=1 %to 29; 
      diff2_&j=rnf1_&j-y&j; 
    %end; 
    %do k=1 %to 20; 
      diff3_&k=rnf3_&k-z&k; 
    %end; 
  %mend; 
%group; 
run; 
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APPENDIX IV: SAS CODE FOR CALCULATING AUC ON TRAINING AND 10-
FLODER CROSS-VALIDATION DATASETS 
 
/* This is a macro to carry out the n-folder cross validation. 
 
   It is modified from nfolder_mac.sas. It takes 3 sets of variables. 
 
   file name: nfolder_mac.sas 
   last updated: May 22, 2002 
   by: Fan Xu 
   Modified by: Hailun Wang 
 
*/ 
 
 
%include 'k:\intern\spectrx\fan\macros\rocest_mac.sas'; 
 
%macro nfolder(datain = model, folder = n, response = whole, var1 =, var2 = , var3 = , 
n = , select = stepwise,  
 print = no, sig = 0.01, pap = no); 
  option nonotes; 
 
  %foldermark(datain = &datain, folder = &folder); 
   
  /*proc princomp data = mark noprint out = prin prefix; 
  var &var1; 
  run;*/  
   
  %do i = 1 %to &folder; 
 
   %put &i out of &folder running...; 
   data oneout; set mark; 
  if group = &i then &response = .; 
 run; 
 
    proc logistic data = oneout descending noprint; 
  %if %upcase(&pap) = YES %then %do; 
       model &response = &var1 /*pm1-pm&n ps1-ps&n pt1-pt&n*/ 
preferredPap 
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  %end; 
  %if %upcase(&pap) = NO %then %do; 
       model &response = &var1 /*pm1-pm&n ps1-ps&n pt1-pt&n*/ 
  %end; 
   %if %upcase(&select) = STEPWISE %then %do; 
     / fast selection = stepwise sle = &sig sls = &sig; 
   %end; 
   %else %do; 
      
    ; 
   %end;  
      output out = lout pred = pred; 
    run; 
 
 data pred1; set lout; if group = &i ; keep pred; run; 
 data pred2; set mark; if group = &i ; keep &response; run; 
 data pred; merge pred1 pred2; run; 
 
    %if &i = 1 %then %do; 
        data valid; set _null_; run; 
    %end; 
 
 data valid; set valid pred; run; 
  %end; 
 
  proc logistic data = mark noprint descending ; 
  %if %upcase(&pap) = YES %then %do; 
       model &response = &var1 /* pm1-pm&n ps1-ps&n pt1-pt&n */  
preferredPap 
  %end; 
  %if %upcase(&pap) = NO %then %do; 
       model &response = &var1 /*pm1-pm&n ps1-ps&n pt1-pt&n */ 
  %end; 
   %if %upcase(&select) = STEPWISE %then %do; 
     /  selection = stepwise sle = &sig sls = &sig; 
   %end; 
   %else %do; 
      
   ; 
   %end;  
    output out = lout pred = pred; 
  run; 
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  %if %upcase(&print) = YES %then %do; 
   %rocest(datain = lout, tests = pred, gold = &response);   
   title 'Training Performance'; 
   proc print data = roc; run; 
   %rocest(datain = valid, tests = pred, gold = &response); 
   title 'Cross-Validation Performance'; 
   proc print data = roc; run; 
  %end; 
%mend; 
 
%macro foldermark(datain = , folder = ); 
 
 proc sort data = &datain; by whole1; run; 
 
 data mark; set &datain;  
  by whole1; 
  if first.whole1 then obs = 0; 
  else obs + 1; 
  if last.whole1 then do; 
       
   if whole1=3.2 then do; 
    call symput('groupobs3_2', round(obs / &folder)); 
   end; 
 
   if whole1=3.5 then do; 
     call symput('groupobs3_5', round(obs / &folder)); 
   end; 
    
   if whole1=3 then do; 
     call symput('groupobs3', round(obs / &folder)); 
   end; 
 
   if whole1=2.5 then do; 
    call symput('groupobs2_5', round(obs / &folder)); 
   end; 
 
   if whole1=2 then do; 
     call symput('groupobs2', round(obs / &folder)); 
   end; 
    
   if whole1=1 then do; 
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     call symput('groupobs1', round(obs / &folder)); 
   end; 
 
            if whole1=0 then do; 
     call symput('groupobs0', round(obs / &folder)); 
   end; 
 
  end; 
 run; 
 
 data mark; set mark; 
  if whole1 = 0 then group = int(obs / &groupobs0) + 1; 
  if whole1 = 1 then group = int(obs / &groupobs1) + 1; 
  if whole1 = 3 then group = int(obs / &groupobs3) + 1;   
  if whole1 = 3.2 then group = int(obs / &groupobs3_2) + 1;   
  if whole1 = 3.5 then group = int(obs / &groupobs3_5) + 1;   
  if group > &folder then group = &folder; 
 run; 
 
%mend; 
 
%include 'K:\intern\spectrx\workdir\programs\nfolder3_mac.sas'; 
 
data train; 
 set Point_diff; 
 whole1=pathology; 
 if whole1 not in (2 2.5); 
 if pathology not in (-1 -2 9 999); 
 whole = (whole1 > 2); 
 high = (whole1 >= 3); 
 highlow = (whole1 >= 2); 
 low = whole1 in (2 2.5); 
run; 
 
proc logistic data=train descending noprint; 
  model whole= diff1_1-diff1_31 diff2_1-diff2_29 diff3_1-diff3_20/ scale=none 
                            clparm=wald 
                            clodds=pl 
                            rsquare 
                            outroc=roc1; 
  output out=lout pred=pred p=prob XBETA=beta;  
 run; 
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data indice1; 
  set lout(keep=sub_id point pred); 
  if _n_<16000; 
run; 
 
data indice2; 
  set lout(keep=sub_id point pred); 
  if _n_>=16000; 
run; 
/*logistic 1.1(full)*/ 
%nfolder(datain = Train, folder = 10, response = whole, var1 = diff1_1-diff1_31 
diff2_1-diff2_29 diff3_1-diff3_20, var2 = , var3 = , n =3 , select = forward,  
 print = yes, sig = 0.01, pap = no); 
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APPENDIX V: SAS CODE FOR DATA MANIPULATION AND PERCENTILE 
VARIABLE CREATION IN WHOLE CERVIX DIAGNOSIS 
 
/*  
This is data manipulation to read 522 subjects with spectrum 410+ 
into sas data set .  
 
Hailun Wang 
last update: 02/28/2007 
*/ 
 
%include 'G:\intern\spectrx\fan\missing_mac.sas'; 
libname After 'G:\intern\whole cervix model\sas data'; 
 
option nonotes; 
options nonumber nodate;  
%macro readdata(path1 = , path2 = , path3 = , file = , spacing = 10, dataout =,  
  subselect = 1, pointselect = 0, disq = yes, extype = manual); 
 
 data demo; 
 infile "&path1&file" expandtabs lrecl = 10000 missover; 
    input sub_id$ available unclean datec$ whole1 sitepath qa1 PriorPap PriorPaptype 
  DayofPap DayofPaptype PreferredPap PreferredPaptype scjvisible 
colpoadequacy Age Race 
  menstrual Menopause Gravida Para Abort Birthcontrol Priorsurgery1 
DaysPriorsurgery1 
  Priorsurgery2 DaysPriorsurgery2 Priorsurgery3 DaysPriorsurgery3  
  Priorsurgery4 DaysPriorsurgery4 Priorsurgery5 DaysPriorsurgery5 height 
weight  
  smoking Cigarettesperday; 
 d_id = substr(sub_id, 1, 1); 
 year = substr(datec, 1, 4); month = substr(datec, 5, 2); day = substr(datec, 7, 2); 
 date = mdy(month, day, year); 
 %nmissing(varlist = available unclean whole1 sitepath qa1 PriorPap 
PriorPaptype 
  DayofPap DayofPaptype PreferredPap PreferredPaptype scjvisible 
colpoadequacy Age Race 
  menstrual Menopause Gravida Para Abort Birthcontrol Priorsurgery1 
DaysPriorsurgery1 
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  Priorsurgery2 DaysPriorsurgery2 Priorsurgery3 DaysPriorsurgery3  
  Priorsurgery4 DaysPriorsurgery4 Priorsurgery5 DaysPriorsurgery5 height 
weight  
  smoking Cigarettesperday, missing = -1 -2); 
 if available and &subselect; 
 run; 
 
 
 proc sort data = demo; by sub_id; run; 
 
 data _null_; set demo end = last; 
    call symput('sub'||left(_n_), trim(left(sub_id))); 
    if last then call symput('nsub', _n_);   
 run; 
 
 proc sort data = demo; by sub_id; run; 
 
 data coordinates; 
 infile 
'G:\intern\spectrx\fan\nci\hybrid\data3\HybridInterrogationPointCoordsmm.txt' 
expandtabs; 
 input point x y; 
 run; 
 
 %do i = 1 %to &nsub; 
  %put Read Data File For Subject #&i out of %left(&nsub) &&sub&i; 
   
  Data org; 
 /*infile "&path2.&&sub&i.._spectra_&spectype..txt" expandtabs lrecl = 
100000;*/ 
 INFILE "&path2.&&sub&i.._spectra_autopeakrowdetect_notiszero2.txt" 
   EXPANDTABS LRECL=100000; 
 %if %upcase(&disq) = NO %then %do; 
     input point rf_1-rf_63 f1_1-f1_63 f2_1-f2_57 f3_1-f3_45; 
  array rf rf_1-rf_63; array f1 f1_1-f1_63; array f2 f2_1-f2_57; array f3 
f3_1-f3_45; 
  %if &spacing = 5 %then %do; 
   %let t1 = 63; %let t2 = 63; %let t3 = 57; %let t4 = 45;  
  %end; 
  %else %if &spacing = 10 %then %do; 
   %let t1 = 31; %let t2 = 31; %let t3 = 28; %let t4 = 22;  
  %end; 
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  %else %if &spacing = 20 %then %do; 
   %let t1 = 15; %let t2 = 15; %let t3 = 14; %let t4 = 11; 
  %end; 
 %end; 
  
 %else %do; 
     input point b1-b4 rf_1-rf_59 b5-b8 f1_1-f1_59 b9-b12 f2_1-f2_53 b13-b16 
f3_1-f3_41; 
  array rf rf_1-rf_59; array f1 f1_1-f1_59; array f2 f2_1-f2_53; array f3 
f3_1-f3_41; 
  %if &spacing = 5 %then %do; 
   %let t1 = 59; %let t2 = 59; %let t3 = 53; %let t4 = 41;  
  %end; 
  %else %if &spacing = 10 %then %do; 
   %let t1 = 29; %let t2 = 29; %let t3 = 26; %let t4 = 20;  
  %end; 
  %else %if &spacing = 20 %then %do; 
   %let t1 = 15; %let t2 = 14; %let t3 = 13; %let t4 = 10;  
  %end; 
 %end; 
 %let t = %eval(&t1 + &t2 + &t3 + &t4); 
 
 %spacingselfnorm; 
 sub_id = "&&sub&i"; 
  run; 
 
  data pointcat; 
 infile "&path3.&&sub&i.._excl_&extype..txt" expandtabs; 
 input point reject; 
  run; 
 
  data org; merge org pointcat coordinates; by point; run; 
 
  %meanpro(datain = org, dataout = m&i); 
 
 %end; 
  
  data model; merge demo %mf;  
 by sub_id;  
  run; 
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  data &dataout; set model;  
   CIN31 = (whole1 = 3.5); 
   CIN32 = (whole1 >= 3.2); 
 high = (whole1 >= 3); 
 highlow = (whole1 >= 2); 
 low = whole1 in (2 2.5); 
 nandb = whole1 in (0 1); 
 nc = whole1 = 1; 
 normal = whole1 = 0; 
  run;  
   
%mend; 
 
%macro mf; 
  %do j = 1 %to &nsub; 
    m&j 
  %end; 
%mend; 
 
%macro spacingselfnorm; 
 
 array nrf nrf_1-nrf_&t1; array nf1 nf1_1-nf1_&t2; array nf2 nf2_1-nf2_&t3; 
array nf3 nf3_1-nf3_&t4; 
 array rnrf rnrf_1-rnrf_&t1; array rnf1 rnf1_1-rnf1_&t2; array rnf2 rnf2_1-
rnf2_&t3; array rnf3 rnf3_1-rnf3_&t4; 
 
 %if &spacing = 5 %then %do; 
  do i = 1 to &t1; nrf(i) = rf(i); end; 
  do i = 1 to &t2; nf1(i) = f1(i); end; 
  do i = 1 to &t3; nf2(i) = f2(i); end; 
  do i = 1 to &t4; nf3(i) = f3(i); end; 
 %end; 
 %else %if &spacing = 10 %then %do; 
  do i = 1 to &t1; nrf(i) = (rf(2 * i - 1) + rf(2 * i)) / 2; end; 
  do i = 1 to &t2; nf1(i) = (f1(2 * i - 1) + f1(2 * i)) / 2; end; 
  do i = 1 to &t3; nf2(i) = (f2(2 * i - 1) + f2(2 * i)) / 2; end; 
  do i = 1 to &t4; nf3(i) = (f3(2 * i - 1) + f3(2 * i)) / 2; end; 
 %end; 
 %else %do; 
  do i = 1 to &t1; nrf(i) = (rf(4 * i - 3) + rf(4 * i - 2) + rf(4 * i - 1) + rf(4 * i)) 
/ 4; end; 
  do i = 1 to &t2; nf1(i) = (f1(4 * i - 3) + f1(4 * i - 2) + f1(4 * i - 1) + f1(4 * 
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i)) / 4; end; 
  do i = 1 to &t3; nf2(i) = (f2(4 * i - 3) + f2(4 * i - 2) + f2(4 * i - 1) + f2(4 * 
i)) / 4; end; 
  do i = 1 to &t4; nf3(i) = (f3(4 * i - 3) + f3(4 * i - 2) + f3(4 * i - 1) + f3(4 * 
i)) / 4; end; 
 %end; 
 
 avgnrf = mean(of nrf_1-nrf_&t1); stdnrf = std(of nrf_1-nrf_&t1); 
 avgnf1 = mean(of nf1_1-nf1_&t2); stdnf1 = std(of nf1_1-nf1_&t4); 
 avgnf2 = mean(of nf2_1-nf2_&t3); stdnf2 = std(of nf2_1-nf2_&t4); 
 avgnf3 = mean(of nf3_1-nf3_&t4); stdnf3 = std(of nf3_1-nf3_&t4); 
 
 do i = 1 to &t1; rnrf(i) = nrf(i) / avgnrf; end; 
 do i = 1 to &t2; rnf1(i) = nf1(i) / avgnf1; end; 
 do i = 1 to &t3; rnf2(i) = nf2(i) / avgnf2; end; 
 do i = 1 to &t4; rnf3(i) = nf3(i) / avgnf3; end; 
 
%mend; 
 
 
%macro meanpro(datain = , dataout = ); 
 
  proc means data = &datain noprint; 
  var rnrf_1-rnrf_&t1 rnf1_1-rnf1_&t2 rnf2_1-rnf2_&t3 rnf3_1-rnf3_&t4 ; 
     output out = &dataout 
 
 
  p10 = p10ra1-p10ra&t 
  p25 = p25ra1-p25ra&t 
  p50 = p50ra1-p50ra&t 
  p75 = p75ra1-p75ra&t 
  p90 = p90ra1-p90ra&t; 
  where reject in (&pointselect); 
  by sub_id; 
   
  run;  
 
%mend; 
 
 
%readdata(path1 = 
\\SPRXDEV1\Can1\CCDataAnalysis\PreProcessedData\export\HybridFINAL\ClinicalD
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ata\,  
    path2 = 
\\SPRXDEV1\Can1\CCDataAnalysis\PreProcessedData\export\HybridFINAL\Spectra\a
utopeakrowdetect_notiszero2\, 
    path3 = 
\\SPRXDEV1\Can1\CCDataAnalysis\PreProcessedData\export\HybridFINAL\Excluded
Points\manual\, 
 
  
 
 file = HybridFINAL_ClinicalData_dm_2.txt, spacing = 10, dataout = 
After.clean522, disq = yes, 
    subselect = (unclean = 0 and whole1~= .)); 
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APPENDIX VI: SAS CODE FOR READ PILOT DATA INTO ALPHA PICK AND 
BETA PICK SETS 
 
/**************************************************** 
This is a program to read alpha polit data and generate  
p10-p90 var and ratio var 
*****************************************************/  
 
 
libname After 'G:\intern\whole cervix model\sas data'; 
 
option nonotes; 
options nonumber nodate;  
 
%macro readdata (pointselect=, extype = , dataout=); 
 
proc import datafile="G:\intern\whole cervix model\pilot\clinicaldata_epa.xls" 
out=demo dbms=excel; 
 
data demo; 
  set demo; 
  if whole1=. then delete; 
  sub_id=substr(subject,6,4); 
run; 
 
 proc sort data = demo; by sub_id; run; 
 
 data _null_; set demo end = last; 
    call symput('sub'||left(_n_), trim(left(sub_id))); 
    if last then call symput('nsub', _n_);   
 run; 
 %do i = 1 %to &nsub; 
  %put Read Data File For Subject #&i out of %left(&nsub) &&sub&i; 
   
  %macro spacingselfnorm; 
 
 array nrf nrf_1-nrf_&t1; array nf1 nf1_1-nf1_&t2; array nf3 nf3_1-nf3_&t4; 
 array rnrf rnrf_1-rnrf_&t1; array rnf1 rnf1_1-rnf1_&t2; array rnf3 rnf3_1-
rnf3_&t4; 
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  do i = 1 to &t1; nrf(i) = (rf(2 * i - 1) + rf(2 * i)) / 2; end; 
  do i = 1 to &t2; nf1(i) = (f1(2 * i - 1) + f1(2 * i)) / 2; end; 
  do i = 1 to &t4; nf3(i) = (f3(2 * i - 1) + f3(2 * i)) / 2; end; 
 
 avgnrf = mean(of nrf_1-nrf_&t1);  
 avgnf1 = mean(of nf1_1-nf1_&t2);  
 avgnf3 = mean(of nf3_1-nf3_&t4);  
 
 do i = 1 to &t1; rnrf(i) = nrf(i) / avgnrf; end; 
 do i = 1 to &t2; rnf1(i) = nf1(i) / avgnf1; end; 
 do i = 1 to &t4; rnf3(i) = nf3(i) / avgnf3; end; 
 
  %mend; 
 
 
  Data org; 
 infile "G:\intern\whole cervix 
model\pilot\Spectra_alpha\11EPA&&sub&i.._spectra.txt" expandtabs lrecl = 100000; 
        input point b1-b4 rf_1-rf_58 b5-b9 f1_1-f1_58 b10-b14 f3_1-f3_41; 
 
        array rf rf_1-rf_59; array f1 f1_1-f1_59; array f3 f3_1-f3_40; 
  %let t1 = 29; %let t2 = 29; %let t4 = 20;  
     %let t = %eval(&t1 + &t2 + &t4); 
 
 %spacingselfnorm; 
 sub_id = "&&sub&i"; 
  run; 
 
 
  data pointcat; 
 infile "G:\intern\whole cervix 
model\pilot\2filtercombo_alpha\11EPA&&sub&i.._excl_&extype..txt" expandtabs; 
 input point reject; 
  run; 
 
  data org; merge org pointcat; by point; run; 
 
  %meanpro(datain = org, dataout = m&i); 
 
 %end; 
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  data model; merge demo %mf;  
 by sub_id;  
  run; 
  
 
  data &dataout; set model;  
   CIN31 = (whole1 = 3.5); 
   CIN32 = (whole1 >= 3.2); 
 high = (whole1 >= 3); 
 highlow = (whole1 >= 2); 
 low = whole1 in (2 2.5); 
 nandb = whole1 in (0 1); 
 nc = whole1 = 1; 
 normal = whole1 = 0; 
  run;  
   
%mend; 
 
%macro mf; 
  %do j = 1 %to &nsub; 
    m&j 
  %end; 
%mend; 
 
%macro meanpro(datain = , dataout = ); 
 
  proc means data = &datain noprint; 
  var rnrf_1-rnrf_&t1 rnf1_1-rnf1_&t2 rnf3_1-rnf3_&t4 ; 
     output out = &dataout 
 
  p10 = p10ra1-p10ra&t 
  p25 = p25ra1-p25ra&t 
  p50 = p50ra1-p50ra&t 
  p75 = p75ra1-p75ra&t 
  p90 = p90ra1-p90ra&t; 
  where reject in (&pointselect); 
  by sub_id; 
   
  run;  
 
%mend; 
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%readdata( pointselect = 0, extype = 2filtercombo, dataout = polit_alpha); 
 
/**************************************************** 
This is a program to read beta1 polit data and generate  
p10-p90 var and ratio var 
*****************************************************/  
 
 
libname After 'G:\intern\whole cervix model\sas data'; 
 
option nonotes; 
options nonumber nodate;  
 
%macro readdata (pointselect=, extype = , dataout=); 
 
proc import datafile="G:\intern\whole cervix model\pilot\clinicaldata_epb.xls" 
out=demo dbms=excel; 
 
data demo; 
  set demo; 
  if whole1=. then delete; 
  sub_id=substr(subject,6,4); 
run; 
 
 proc sort data = demo; by sub_id; run; 
 
 data _null_; set demo end = last; 
    call symput('sub'||left(_n_), trim(left(sub_id))); 
    if last then call symput('nsub', _n_);   
 run; 
 %do i = 1 %to &nsub; 
  %put Read Data File For Subject #&i out of %left(&nsub) &&sub&i; 
   
  %macro spacingselfnorm; 
 
 array nrf nrf_1-nrf_&t1; array nf1 nf1_1-nf1_&t2; array nf3 nf3_1-nf3_&t4; 
 array rnrf rnrf_1-rnrf_&t1; array rnf1 rnf1_1-rnf1_&t2; array rnf3 rnf3_1-
rnf3_&t4; 
 
  do i = 1 to &t1; nrf(i) = (rf(2 * i - 1) + rf(2 * i)) / 2; end; 
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  do i = 1 to &t2; nf1(i) = (f1(2 * i - 1) + f1(2 * i)) / 2; end; 
  do i = 1 to &t4; nf3(i) = (f3(2 * i - 1) + f3(2 * i)) / 2; end; 
 
 avgnrf = mean(of nrf_1-nrf_&t1);  
 avgnf1 = mean(of nf1_1-nf1_&t2);  
 avgnf3 = mean(of nf3_1-nf3_&t4);  
 
 do i = 1 to &t1; rnrf(i) = nrf(i) / avgnrf; end; 
 do i = 1 to &t2; rnf1(i) = nf1(i) / avgnf1; end; 
 do i = 1 to &t4; rnf3(i) = nf3(i) / avgnf3; end; 
 
  %mend; 
 
 
  Data org; 
 infile "G:\intern\whole cervix 
model\pilot\Spectra_beta\11EPB&&sub&i.._spectra_orig_iscorr_Sequence_1.txt" 
expandtabs lrecl = 100000; 
        input point b1-b4 rf_1-rf_58 b5-b72 f1_1-f1_58 b73-b77 f3_1-f3_40; 
 
        array rf rf_1-rf_58; array f1 f1_1-f1_58; array f3 f3_1-f3_40; 
  %let t1 = 29; %let t2 = 29; %let t4 = 20;  
     %let t = %eval(&t1 + &t2 + &t4); 
 
 %spacingselfnorm; 
 sub_id = "&&sub&i"; 
  run; 
 
 
  data pointcat; 
 infile "G:\intern\whole cervix 
model\pilot\2filtercombo_beta\11EPB&&sub&i.._excl_&extype._sequence_1.txt" 
expandtabs; 
 input point reject; 
  run; 
 
  data org; merge org pointcat; by point; run; 
 
  %meanpro(datain = org, dataout = m&i); 
 
 %end; 
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  data model; merge demo %mf;  
 by sub_id;  
  run; 
  
 
  data &dataout; set model;  
   CIN31 = (whole1 = 3.5); 
   CIN32 = (whole1 >= 3.2); 
 high = (whole1 >= 3); 
 highlow = (whole1 >= 2); 
 low = whole1 in (2 2.5); 
 nandb = whole1 in (0 1); 
 nc = whole1 = 1; 
 normal = whole1 = 0; 
  run;  
   
%mend; 
 
%macro mf; 
  %do j = 1 %to &nsub; 
    m&j 
  %end; 
%mend; 
 
%macro meanpro(datain = , dataout = ); 
 
  proc means data = &datain noprint; 
  var rnrf_1-rnrf_&t1 rnf1_1-rnf1_&t2 rnf3_1-rnf3_&t4 ; 
     output out = &dataout 
 
  p10 = p10ra1-p10ra&t 
  p25 = p25ra1-p25ra&t 
  p50 = p50ra1-p50ra&t 
  p75 = p75ra1-p75ra&t 
  p90 = p90ra1-p90ra&t; 
  where reject in (&pointselect); 
  by sub_id; 
   
  run;  
 
%mend; 
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%readdata( pointselect = 0, extype = 2filtercombo, dataout = polit_beta1); 
libname After 'G:\intern\whole cervix model\sas data'; 
libname Dallas 'G:\intern\whole cervix model\sas data\dallas'; 
libname comb 'G:\intern\whole cervix model\sas data\comb'; 
 
option nonotes; 
options nonumber nodate;  
 
data pilotalpha; 
  set after.politalpha_mixratio;  
  keep subject preferredpap whole1 p10ra1-p10ra78 p25ra1-p25ra78 p50ra1-p50ra78 
p75ra1-p75ra78 p90ra1-p90ra78 r1-r11 m1-m78; 
run; 
   
data pilotbeta1; 
  set after.politbeta1_mixratio; 
  length sub_id $10; 
  machine='B1'; 
  sub_id=machine||subject; 
  keep sub_id preferredpap whole1 p10ra1-p10ra78 p25ra1-p25ra78 p50ra1-p50ra78 
p75ra1-p75ra78 p90ra1-p90ra78 r1-r11 m1-m78; 
run; 
 
 
data dallas2; 
  set dallas.dallas2_10remove_mixratio; 
  keep sub_id subject priorpap whole1 p10ra1-p10ra78 p25ra1-p25ra78 p50ra1-p50ra78 
p75ra1-p75ra78 p90ra1-p90ra78  m1-m78 r1-r11; 
  rename priorpap=preferredpap sub_id=subject; 
run ; 
 
data comb.comb1; 
  length subject $10.; 
  merge dallas2 pilotalpha; 
  by subject; 
run; 
 
data comb.comb2; 
  merge pilotbeta1; 
  by sub_id; 
run; 
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APPENDIX VII: SAS CODE FOR T-TEST, WILCOXON TEST 
 
/*****This is program to conduct ttest for 15 single variables and 78 mixed 
varialbes****/ 
 
libname After 'G:\intern\whole cervix model\sas data'; 
 
data ttest; 
set after.diffpt; 
if whole1 not in (2 2.5); 
if whole1>=3 then group=1; else group=2; 
run; 
 
%macro ttest1; 
 
%do i=1 %to 78; 
ods listing close; 
ods trace on; 
ods output Stat.TTest.TTests=m&i; 
 
proc ttest data=ttest; 
class group; 
var m&i; 
run; 
%end; 
 
%mend; 
 
%ttest1; 
 
 
data result; 
  set %mj1; 
  if method='Satterthwaite'; 
run; 
 
%macro mj1; 
%do j=1 %to 78; 
m&j 
%end; 
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%mend; 
 
data result; 
  length variable $6.0; 
  set %mj1; 
  if method='Satterthwaite'; 
run; 
 
proc sort data=result; 
  by probt; 
run; 
 
 
/*****This is program to conduct ttest for model2.3 and 78 mixed varialbes****/ 
 
data ttest; 
set after.clean510_ratio; 
if whole1 not in (2 2.5); 
if whole1>=3 then group=1; else group=2; 
run; 
 
ods listing close; 
ods trace on; 
ods output Stat.TTest.TTests=allvar; 
 
proc ttest data=ttest; 
class group; 
var p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 r1-r11; 
run; 
 
data result2; 
  length variable $8.0; 
  set allvar result; 
  if method='Satterthwaite'; 
run; 
 
proc sort data=result2; 
  by probt; 
run; 
 
/********wilcoxon test*****************/ 
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options nonotes nodate;  
libname after 'G:\intern\whole cervix model\sas data'; 
 
data cin1out; set after.clean510_dmratio; if whole1 not in (2 2.5); whole = (whole1 > 2); 
run;  
 
 
proc npar1way wilcoxon data=cin1out noprint; 
      class whole; 
      var p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57 p75ra58 r1-r11 
dmr1-dmr18 d1-d8; 
   output out=all wilcoxon; 
run; 
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APPENDIX VIII: SAS CODE FOR GENERATING COEFFICIENTS OF ALL 
WHOLE CERVIX MODEL 
 
/*This is a program to generate coefficients for all models*/ 
 
libname after 'G:\intern\whole cervix model\sas data'; 
/*model 1.0*/ 
data cin1out; set after.p25_80var;if whole1 not in (2 2.5); whole = (whole1 >=3); run; 
  
proc pls data = cin1out ; 
 model high = p25ra1-p25ra80/solution; 
run; 
 
/*model1.01*/ 
data all; set After.p25_80var; whole=int(whole1); run;  
 
proc pls data = all ; 
 model whole = p25ra1-p25ra80/solution; 
run; 
 
/*model1.02 */ 
data cin1out; set After.clean510; if whole1 not in (2 2.5); whole = (whole1 >=3); run;  
 
proc pls data = cin1out noprint; 
 model high = p25ra1-p25ra58 p25ra85-p25ra104/solution; 
run; 
 
 
/*model1.03*/ 
data all; set After.clean522; whole=int(whole1); run;  
 
proc pls data = all ; 
 model whole = p25ra1-p25ra58 p25ra85-p25ra104/solution; 
 output out = fan2 predicted=fan2; 
run; 
 
/*helen's 15 var model*/ 
data cin1out; set After.clean510; if whole1 not in (2 2.5); whole = (whole1 >=3); run; 
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proc pls data = cin1out noprint; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58/solution; 
 output out = var15 predicted = var15; 
run; 
 
/*helen's 15+ratio var model*****************Model 2.3*********/ 
data cin1out; set After.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out noprint; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 r1-r11/solution; 
run; 
 
/*mixed percentile model*/ 
data cin1out; set After.clean510; if whole1 not in (2 2.5); whole = (whole1 >=3); run;  
 
proc pls data = cin1out noprint; 
 model high = p25ra1-p25ra19 p25ra30-p25ra38 p25ra85-p25ra94 p75ra20-
p75ra29 p75ra39-p75ra58 p75ra95-p75ra104/solution; 
    output out=mix1 predicted = mix1; 
run; 
 
/*mixed percentile mode2*/ 
 
data cin1out; set After.clean510; if whole1 not in (2 2.5); whole = (whole1 >=3); run;  
 
proc pls data = cin1out noprint; 
 model high = p25ra1-p25ra19 p25ra30-p25ra38 p25ra85-p25ra94 p90ra20-
p90ra29 p90ra39-p90ra58 p90ra95-p90ra104/solution; 
    output out=mix2 predicted = mix2; 
run; 
 
/*chenghong's 1.5*/ 
 
data cin1out; set after.diffpt; if whole1 not in (2 2.5); whole = (whole1 >=3); run; 
proc pls data = cin1out noprint; 
 model whole = p25ra1-p25ra17 p25ra22-p25ra35 p25ra39-p25ra58 p25ra85-
p25ra92 p25ra95-p25ra104/solution; 
 output out = ch1_5 predicted = ch1_5; 
run; 
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/*chenghong's 1.9*/ 
 
data cin1out; set after.diffpt; if whole1 not in (2 2.5); whole = (whole1 >=3); run; 
proc pls data = cin1out; 
 model whole = p25ra8-p25ra19 p25ra22-p25ra35 p25ra39-p25ra58 p25ra85-
p25ra104 m1-m12 m18-m28 m31 m32/solution; 
 output out = ch1_9 predicted = ch1_9; 
run; 
 
/*510 no cin1 model output*/ 
data fan2; 
  set fan2; 
  if whole1 not in (2 2.5); 
run; 
 
data total; 
  merge fan2 var15 ch1_5 ch1_9 mix1 mix2; 
  by sub_id; 
  keep sub_id preferredpap whole1 fan2 var15 ch1_5 ch1_9 mix1 mix2;  
  if fan2=. then delete; 
run; 
 
 
/*****************Model 2.3 with CIN1 cases in********************/ 
data all; set After.clean510_ratio; select (whole1); 
  when (0) high=0; 
  when (1) high=1; 
  when (2) high=2; 
  when (2.5) high=3; 
  when (3,3.2,3.5) high=4; 
end; 
run; 
 
proc pls data = all; 
 model high = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 r1-r11/solution; 
 output out = model2_3_all predicted = pred; 
run; 
 
data output; 
  set model2_3_all; 
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  keep sub_id whole1 preferredpap pred; 
run; 
 
/*******************10 folder cv on Model 2.3**************/ 
  
data cin1out; set After.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out cv=split(10) noprint; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 r1-r11/solution; 
run; 
 
/*****************Model 2.3 + pap +Mars***********/ 
 
data cin1out; 
  set After.clean510_ratio;  
    if whole1 not in (2 2.5); whole = (whole1 >=3);  
   if preferredpap eq 3 or preferredpap eq 4 then 
   BF1 = 1; 
   else 
   BF1 = 0; 
 
      if (preferredpap eq  0 or preferredpap eq 1 or preferredpap eq 3) then 
   BF3 = 1; 
   else 
   BF3 = 0; 
run;  
 
proc pls data = cin1out; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 r1-r11 preferredpap BF1 BF3/solution; 
run;  
 
 
/*******************model 2.43 new: model 2.3 train by 451 data (apply 15-exclude 
rule to 510 data)**********/ 
data cin1out; set After.retrain510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out  noprint; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
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p75ra58 r1-r11/solution; 
run; 
 
/***************model 2.44: 15 single var + david 18 ratio + 8 difference 
var***********/ 
data cin1out; set after.clean510_dmratio; if whole1 not in (2 2.5); whole = (whole1 
>=3); run; 
 
proc pls data = cin1out; 
 model whole =p25ra1-p25ra4 p25ra30-p25ra32 p75ra25-p75ra29 dmr1-dmr3 
dmr5-dmr6 dmr9 dmr11 dmr14-dmr15 d1 d3 d4 d7 / solution; 
run;  
 
/***************model 2.45: min/max ratio variables**********/ 
data cin1out; set after.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out; 
 model whole = p10m1 p25m1 p25m2 p50m1 p75m1 p75m2 p90m1 p10_75m1 
p10_75m2 p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 p25_75m1 
p25_75m2 p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3/solution; 
run; 
/*************model 2.46: 15 single var + 22 min/max ratio variables********/ 
data cin1out; set after.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 p10m1 p25m1 p25m2 p50m1 p75m1 p75m2 p90m1 p10_75m1 p10_75m2 
p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 p25_75m1 p25_75m2 
p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3/solution; 
run; 
 
/**************model 2.47: reduce 2.45 to 11 vars***********/ 
data  cin1out; set after.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out; 
 model whole = p10m1 p25m1 p25m2 p75m2 p90m1 p10_75m2 p10_90m1 
p25_75m2 p25_75m4 p25_75m5 p25_90m3/solution; 
run; 
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/*************model 2.48: 15 single var + 11 min/max********/ 
data  cin1out; set after.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 p10m1 p25m1 p25m2 p75m2 p90m1 p10_75m2 p10_90m1 p25_75m2 
p25_75m4 p25_75m5 p25_90m3/solution; 
run; 
 
/*************model 2.46+pap: 15 single var + 22 min/max ratio+pap 
variables********/ 
 
data cin1out; set after.clean510_ratio; if whole1 not in (2 2.5); whole = (whole1 >=3); 
run; 
 
proc pls data = cin1out; 
 model whole = p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-
p75ra58 p10m1 p25m1 p25m2 p50m1 p75m1 p75m2 p90m1 p10_75m1 p10_75m2 
p10_75m3 p10_75m4 p10_90m1 p10_90m2 p10_90m3 p25_75m1 p25_75m2 
p25_75m3 p25_75m4 p25_75m5 p25_90m1 p25_90m2 p25_90m3 
preferredpap/solution; 
run; 
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APPENDIX IX: SAS CODE FOR SENSITIVITY AND SPECIFICITY 
CALCULATION 
 
libname After 'G:\intern\whole cervix model\sas data'; 
libname Dallas 'G:\intern\whole cervix model\sas data\dallas'; 
 
%macro sspec(datain=, applydata=, var1=, var2=, scale=); 
data cin1out; set &datain; if whole1 not in (2 2.5); whole = (whole1 > 2); run;  
data apply_cin1out; set &applydata; if whole1 not in (2 2.5); whole = (whole1 > 2); run;  
 
 
ods listing close; 
ods html close; 
ods trace off; 
 
ods output ParameterEstimates=solution; 
proc pls data = cin1out; 
 model high = &var1/solution; 
run; 
 
data solution(keep=high rename=(high=coeff)); 
  set solution; 
run; 
 
data response (KEEP= whole);  
  set apply_cin1out; 
run; 
 
DATA INPUTS (KEEP= &var2); 
 set apply_cin1out; 
RUN;  
 
option notes; 
ods listing; 
 
PROC IML; 
 
START Sens_Spec; 
USE INPUTS; 
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READ ALL VAR _ALL_ into X; 
CLOSE INPUTS; 
 
USE response; 
READ ALL VAR _ALL_ into whole;  
CLOSE response; 
 
USE SOLUTION; 
READ ALL VAR _ALL_ into coefficients; 
CLOSE SOLUTION; 
 
Z=NROW(coefficients); 
 
M2= coefficients[2:Z,1:1]; 
 
 
/*  Calculate all the response variables */ 
 
Y2= coefficients[1,1] + X* M2; 
N = NROW(Y2); 
 
 
O=J(1000,4,0); 
 
DO J=1 TO 1000 by 1; 
 
     
 CUTOFF= &scale + J * 0.001; 
 R = J(N, 1, CUTOFF); 
   
    Diff = Y2 - R; 
 
 
    ALL = WHOLE[LOC(WHOLE=1),]; 
    COUNT_ALL = NROW(ALL);     
 
    DIF = DIFF[LOC(WHOLE=1),]; 
 indices = LOC(DIF>0); 
  
 if nrow(indices) > 0 then 
  do; 
      TEST_P = DIF[LOC(DIF>0),]; 
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      COUNT_P = NROW(TEST_P); 
   SENS = COUNT_P/COUNT_ALL; 
  end; 
 else SENS = 0; 
 
 
    /* FIND SPECIFICITIES */ 
 
 ALL = WHOLE[LOC(WHOLE=0),]; 
    COUNT_ALL = NROW(ALL);     
  
 DIF = DIFF[LOC(WHOLE=0),]; 
 
 indices = LOC(DIF<=0); 
 
    if nrow(indices) > 0 then 
  do; 
      TEST_N = DIF[LOC(DIF<=0),]; 
      COUNT_N = NROW(TEST_N); 
   SPEC = COUNT_N/COUNT_ALL; 
  end; 
 else SPEC = 0; 
 
 
 /* PUT CUTOFF SENS SPEC INTO MATRIX O FOR OUTPUT */ 
 O[J,1]=CUTOFF; 
 O[J,2]=SENS; 
 O[J,3]=1-SPEC; 
 O[J,4]=SPEC; 
 
end; 
 
 
CREATE SSPEC FROM O; 
APPEND FROM O; 
 
FINISH; 
RUN Sens_Spec; 
quit iml; 
run; 
 
data mark (drop=col3 rename=(col1=cutoff col2=sens col4=specs));  
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  set SSPEC; 
run; 
 
%mend; 
/*Fan's model1*/ 
%sspec(datain=After.clean522, applydata=After.clean522, var=p25ra1-p25ra58 
p25ra85-p25ra104, scale=0); 
/*15var+ratio*/ 
%sspec(datain=After.clean522_ratio, applydata=After.clean522_ratio,var1=p25ra1-
p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 r1-r11,  
       var2=p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra31 r1-r11, scale=-0.5); 
/*chenghong's 1.5*/ 
%sspec(datain=After.diffpt, applydata=After.diffpt, var= p25ra1-p25ra17 p25ra22-
p25ra35 p25ra39-p25ra58 p25ra85-p25ra92 p25ra95-p25ra104 
                                 m1-m13 m26-m29, scale=-0.5); 
 
/*chenghong's 1.9*/ 
%sspec(datain=After.diffpt,applydata=After.diffpt, var=p25ra8-p25ra19 p25ra22-
p25ra35 p25ra39-p25ra58 p25ra85-p25ra104 
                                 m1-m12 m18-m28 m31 m32, scale=0.02); 
/*helen's 15var on pilot alpha*/ 
%sspec(datain=After.clean510, applydata=After.politalpha, var1=p25ra1-p25ra5 
p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58,  
        var2=p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58, scale=-
0.5); 
 
/*helen's 15var+ratio on pilot alpha*/ 
%sspec(datain=After.clean510_ratio, applydata=After.politalpha, var1=p25ra1-p25ra5 
p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 r1-r11,  
        var2=p25ra1-p25ra5 p25ra30-p25ra32 p75ra25-p75ra29 p75ra57-p75ra58 r1-r11, 
scale=-0.5); 
 
 
 
 
